רשימת פרסומים

LIST OF PUBLICATIONS : (Black – original, purple – case report, green- review, brown – chapter, blue – abstract, gray – commentary)

1.  Steiner ZP, Brezniak (Livneh) A, Yaretzkey A, Klajman A. A routine bedside procedure elucidating obscure arrhythmias. Isr J Med Sci 11:409-419, 1973.

2.  Shemesh Y, Livneh A, Cabili S. Hepatic encephalopathy due to congestive heart failure. Harefuah 102:66-67, 1982.

3.  Livneh A. Antibodies against the receptor of insulin. Harefuah 108:494-498, 1985.

4.  Livneh A. Antibodies to insulin - Obvious and possible effects. Harefuah 110:458- 462, 1986.

5.  Livneh A, Ram Z. A vaccine against organophosphorous poisoning - Is it possible. Harefuah 110:462-464, 1986.

6.  Livneh A, Avraham H, Elias D, Sack J, Cohen IR, Eshhar Z. A human monoclonal antibody to insulin. Diabetes 35:68-73, 1986.

7.  Livneh A, Halpern A, Perkins D, Diamond B. Use of anti-idiotype to detect a potentially pathogenic subset of anti-DNA antibodies bearing lambda light chains. Arthritis Rheum 29 (Suppl):S-71, 1986.    

8.  Livneh A, Halpern A, Perkins D, Lazo A, Halpern R, Diamond B. A monoclonal antibody to cross reactive idiotype on cationic human anti-DNA antibodies expressing lambda light chain: A new probe for a potentially differential pathogenic subset. J Immunol 138:123-127, 1987.

9.   Livneh A, Preud'homme J-L, Solomon A, Diamond B. High incidence of SLE - associated idiotype on human B cell neoplasm. Arthritis Rheum 30 (Suppl):S-104, 1987.

10.  Davidson A, Shefner R, Livneh A, Diamond B. The role of somatic mutation of immunoglobulin genes in autoimmunity. Ann Rev Immunol 5:85-108, 1987.  

11.  Livneh A, Preud'homme J-L, Solomon A, Diamond B. Preferential expression of the systemic lupus erythematosus associated idiotype 8.12 in sera containing monoclonal immunoglobulins. J Immunol 139:3730-3733, 1987.

12.  Soreq H, Livneh A, Zakut H. The role of human antibodies toward muscle membrane acetylcholinesterase in neuromuscular dysfunction. Ann NY Acad Sci 505: 769-772, 1988.

13.  Livneh A, Coman EA, Cho S, Lipstein-Kresch E. Strongyloides stercoralis hyperinfection mimicking systemic lupus erythematosus flare. Arthritis Rheum 31: 930-931, 1988.

14.  Livneh A, Sarova I, Pras M, Michaeli D, Wagner K, Zakut H, Soreq H. Antibodies against acetylcholinesterase and low levels of cholinesterases in patient with an atypical neuromuscular disorder. Clin Immunol Immunopathol 48:119-131, 1988.

15.  Livneh A, Langevitz P, Morag B, Catania A, Pras M. Functionally reversible hepatic arteriovenous fistules during pregnancy in patients with hereditary hemorrhagic telangictasia. South Med J 81:1047-1050, 1988.

16.  Davidson A, Livneh A, Manheimer-Lory A, Shefner R, Katz JB, Sewell KL, Diamond B. Idiotypic analysis of anti-DNA antibodies in systemic lupus and monoclonal gamopathy. Ann Inst Pasteur Immunol 139:645-650, 1988.

17.  Sewell KL, Livneh A, Diamond B. Analysis of a cloned B cell line bearing an anti-DNA associated idiotype. Arthritis Rheum.32 (Suppl): R-19, 1989.

18.  Livneh A. Fibromyalgia - recent advances. A critical review of the literature. Harefuah 116:316-320, 1989.

19.  Sewell KL, Aranow CB, Livneh A, Grayzel AI. MRI versus CT scanning in neuropsychiatric SLE. Arthritis Rheum. 32:(Suppl) R-13, 1989.

20.  Livneh A, Sewell KL, Barland P. Chronic gonococcal arthritis. J Rheum 16: 245- 246, 1989.

21.  Sewell KL, Livneh A, Aranow CB, Grayzel AI.  MRI versus CT scanning in nonfocal neuropsychiatric SLE. Am J Med 36:625-626, 1989.

22.  Schattner A, Lachmi M, Hahn T, Edlan K, Livneh A, Pras M. Tumor necrosis factor in familial Mediterranean fever. Lancet 2:1050, 1989.

23.  Livneh A, Huszar M, Zemer D, Sohar E, Pras M. Colchicine in the treatment of kidney transplanted FMF patients. XVIIth Ilar Congress of Rheumatology. Book of Abstracts, 218, 1989.

24.  Livneh A, Zemer D, Huszar M, Pras M. Colchicine prevents or delays the development of amyloidosis of the kidney transplant in patients with FMF. 7th Israel Medical Week. Israel Society of Internal Medicine, Book of Abstracts, 10, 1989.

25.  Livneh A, Behar E, Gazit E, Eherenfeld M, Many A. The 8.12 reactive anti-DNA antibodies are elicited in response to foreign antigen. 7th Israel Medical Week. The Israel Societies of Allergology, Clinical Immunology and Rheumatology, Book of Abstracts, 7, 1989.

26.  Livneh A, Avraham H, Bistritzer T, Weissglass L, Theodor R, Sack J. Deleterious effect of anti-insulin antibodies on diabetes control. Isr J Med Sci 26: 11-15, 1990.

27.  Gruberg L, Livneh A, Rozenman J, Pras M. Pulmonary disease induced by low dose methotrexate for rheumatoid arthritis. Harefuah 118:178-181, 1990.

28.  Livneh A. A search for an autoimmune immunoglobulin gene. Harefuah 118:178- 181, 1990.

29.  Paul E, Manheimer-Lory A, Livneh A, Solomon A, Aranow C, Ghossein C, Shefner R, Offen D, Pillinger M, Diamond B. Pathogenic anti-DNA antibodies in SLE: Idiotypic families and genetic origins. Intern Rev Immunol 5:295-313, 1990.

30.  Livneh A, Zemer D, Huszar M, Siegal B, Sohar E, Pras M. Colchicine in the treatment of kidney transplanted FMF patients. Progress Rheum IV:50-51, 1990.   

31.  Lachmi M, Hahn T, Livneh A, Edlan C, Zemer D, Pras M, Schattner A. Tumor necrosis factor in patients with familial Mediterranean fever (FMF) with and without arthritis. Progress Rheum IV:25-30, 1990.       

32.  Grayzel A, Solomon A, Livneh A, Diamond B. Anti-pneumococcal antibodies induced by immunization with polyvalent pneumococcal vaccine bear anti-DNA associated idiotypes. Arthritis Rheum 33 (Suppl):R-42, 1990.

33.  Gao X, Gazit E, Livneh A, Stastny P. Rheumatoid arthritis in Israeli Jews: Association with two sequences shared by several DRB1 alleses in the third hypervariable region. Human Immunol (Abstracts): 69, 1990.

34.  Gao X, Gazit E, Livneh A, Stastny P. Sequence of amino acids in the third hypervariable region of HLA-DRB1 associated with rheumatoid arthritis in Israeli Jews. Arthritis Rheum 33 (Suppl): S-78, 1990.

35.  Katz J, Marmary Y, Livneh A, Danon Y. Drug allergy in Sjogrens syndrome. Lancet 337:239, 1991.

36.  Swissa M, Schul V, Korish S, Livneh A, Pras M, Shoenfeld Y. Determination of autoantibodies in patients with familial Mediterranean fever and their first degree relatives. J Rheumatol 18: 606-608, 1991.

37.  Gao X, Brautbar C, Gazit E, Segal R, Naparstek Y, Livneh A, Stastny P. A variant of HLA-DR4 determines susceptibility to rheumatoid arthritis in a subset of Israeli Jews. Arthritis Rheum 34:547-551, 1991. 

38.  Gao X, Gazit E, Livneh A, Stastny P. Rheumatoid arthritis in Israeli Jews: Shared sequences in the third hypervariable region of DRB1 Alleles are associated with susceptibility. J Rheumatol 18:801-803, 1991.

39.  Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 34: 973-977, 1991.

40.  Paul E, Livneh A, Manheimer-Lory AJ, Diamond B. Characterization of the human immunoglobulin V‚II gene family and analysis of V‚II and C‚ polymorphism in systemic lupus erythematosus. J Immunol 147: 2771-2776, 1991.    

41.  Livneh A, Sharma K, Sewell KL, Keiser HD. Multisystem disease in post-streptococcal arthritis. Ann Rheum Dis 50:328-329, 1991.

42.  Livneh A, Zemer D, Pras M, Shoenfeld Y. Activity scores in systemic lupus  erythematosus. Harefuah 120:134-138, 1991.

43.  Abergil A, Livneh A. Kidney biopsy in systemic lupus erythematosus. Harefuah 120:333-336, 1991. 

44.  Zemer D, Danon YL, Livneh A, Pras M. Chronic colchicine treatment in children with familial Mediterranean fever (FMF). Scand J Rheumatol 89 (Suppl): 17, 1991.

45.  Katz J, Barak S, Livneh A. Primary herpetic gingivostomatitis in the differential diagnosis of sore throat in young adults. Isr J Med Sci 27:418, 1991.

46.  Schattner A, Lachmi M, Livneh A, Pras M, Hahn T. Tumor necrosis factor in familial Mediterranean fever. Am J Med 90: 434:438, 1991.

47.  Behar E, Carp H, Livneh A, Gazit E. Anti idiotypic IgM antibodies to anti HLA Class I antibodies in habitual abortion. Am  J Reprod Immunol 26:143-146, 1991.

48.  Shohat M, Livneh A, Zemer D, Pras M. Twin study in familial Mediterranean fever - a genetic disorder with marked variability in clinical expression. Am J Hum Genetics 49 (Suppl):164, 1991.

49.  Livneh A, Or G, Gazit E, Pras M. Peripheral B cells of SLE and normal individuals secrete antibodies to DNA of similar quality. 8th Israel Medical Week. The Israel Societies of Allergology, Clinical Immunology and Rheumatology, Book of Abstracts, 2, 1991. 

50.  Fischel T, Shemesh E, Goldstein N, Livneh A. An outbreak of foodborne streptococcal pharyngitis and tonsillitis. 8th Israel Medical Week. The Israel Defence Force Medical Corps, Book of Abstracts, 2, 1991. 

51.  Gofrit N, Livneh A. Stress fractures of bone in conscripted infantry recruits. Epidemiology and correlation to physical fitness. 8th Israel Medical Week. The Israel Defence Force Medical Corps, Book of Abstracts, 4, 1991.

52.  Livneh A, Behar E, Many A, Ehrenfeld M, Gazit E, Diamond B. Lupus anti-DNA antibodies bearing the 8.12 idiotype appear to be somatically mutated.  J Clin Immunol 12: 11-16, 1992.

53.  Livneh A, Zemer D,  Siegal B, Laor A, Sohar E, Pras M. Colchicine prevents kidney-transplant amyloidosis in familial Mediterranean fever (FMF). Nephron 60:  418-422, 1992.

54.  Blum A, Seligmann H, Livneh A, Ezra D. Severe gastrointestinal bleeding induced by hydroxycoumarin-bezafibrate. Isr J Med Sci 28:47-49, 1992.

55.  Zemer D, Livneh A, Langevitz P. Reversal of the nephrotic syndrome by colchicine in amyloidosis of familial Mediterranean fever. Ann Intern Med 116:426, 1992.

56.  Katz J, Weinstein E, Barak S, Livneh A. Periodontal disease in the differential diagnosis of fever of unknown origin. Ann Dentistry 51:3-5, 1992.

57.  Shohat M, Livneh A, Zemer D, Pras M, Sohar E. Twin studies in familial Mediterranean fever. Am J Med Genetics 44: 179:182, 1992.

58.  Paul E, Iliev AA, Livneh A, Diamond B. The anti-DNA associated idiotype 8.12 is encoded by the Vλ II gene family and maps to the vicinity of L chain CDR1. J Immunol 149:3588-3595, 1992.

59.  Cabili S, Livneh A, Zemer D, Rabinovitch O, Pras M. The effect of pregnancy on renal function in amyloidosis of FMF. Am J Reprod Immunol. 28:243-244, 1992.

60.  Zemer D, Livneh A, Pras M, Sohar E. The kidney in familial Mediterranean fever. Contrib Nephrol. 102:187-197, 1993.

61.  Zemer D, Livneh A, Pras M, Sohar E. Familial Mediterranean fever in the colchicine era. The fate of one family. Am J Med Genetics 45:340-344, 1993.

62.  Livneh A, Or G, Many A, Gazit E, Diamond B. Anti-DNA antibodies secreted by peripheral B cells of lupus patients have both normal and lupus specific features. Clin Immunol Immunopathol 68:68-73, 1993.

63.  Livneh A, Cabili S, Zemer D, Rabinovitch O and Pras M. Effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. J Rheumatol 20: 1519- 1523, 1993.

64.  Behar E, Carp H, Livneh A, Gazit E. Differential suppression activity induced by paternal Leukocytes immunization in habitual abortion. Gynecol Obstet Invest 36: 202-207, 1993.  

65.  Livneh A, Zemer D, Langevitz P, Shemer J, Sohar E, Pras M. Colchicine in the treatment of AA and AL amyloidosis. Semin Arthritis Rhem 23:206-214, 1993.

66.  Kushnir T, Livneh A, Langevitz P, Pras M, Itzchak Y. Magnetic resonance imaging of familial Mediterranean fever (FMF). Proceedings of the Society of Magnetic Resonance in Medicine. 2:822, 1993.

67.  Zemer D, Livneh A, Langevitz P, Shemer J, Pras M. Therapeutic attempts in amyloidosis. XIIth International Congress in Nephrology, Book of Abstracts 495, 1993.                          

68.  Pras M, Langevitz P, Livneh A, Zemer D. Correlation between clinical symptoms and chemical structure of amyloid fibrils XIIth International Congress in Nephrology, Book of Abstracts 494, 1993.

69.  Shemesh E, Fischel T, Goldstein N, Alkan M, Livneh A. An outbreak of foodborne streptococcal throat infection. Isr J Med Sci 30:275-278, 1994.

70.  Livneh A, Langevitz P, Vered Z. Atrial septal aneurysm and paroxysmal atrial fibrillation  Harefuah 126: 441-442, 1994.

71.  Livneh A, Madgar I, Langevitz P, Zemer D. Recurrent episodes of acute scrotum and orchiectomy in a patient with familial Mediterranean fever (FMF). J Urol 1511:431-432, 1994.

72.  Pras M, Langevitz P, Livneh A, Zemer D. Vasculitis in familial Mediterranean fever (FMF). Rheumatol in Europe 23: (Suppl 2) 33-34, 1994.

73.  Livneh A, Fischel T. Foodborne streptococcal throat infection. Isr J Med Sci 30: 552, 1994.

74.  Gofrit NO, Livneh A. Stress fractures of bone in conscripted infantry recruits. Relation to pre-army physical fitness. Milit Med 159:339-341, 1994.

75.  Katz J, Langevitz P, Shlomo B, Joshua S, Livneh A. Treatment of recurrent aphthous stomatitis with colchicine. J Am Acad Dermatol 31:459-461, 1994.

76.  Livneh A, Gazit E, Diamond B. The preferential expression of the anti-DNA associated 8.12 idiotype in lupus is not genetically controlled. Autoimmunity 18:1-6, 1994.

77.  Langevitz P, Zemer D, Livneh A, Shemer J, Pras M. Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 21:1708-1709, 1994.

78.  Livneh A, Zaphrir O, Epstein Y. Accidental hypothermia possibly caused by antecedent heat stroke. Postgraduate Med J 70:666-667, 1994.

79.  Langevitz P, Livneh A, Zemer D, Shemer J, Pras M. Seronegative spondyloarthropathy (SNSA) in familial Mediterranean fever (FMF). Arthritis Rheum 37 (Suppl):S-203, 1994.

80.  Pauzner R, Dolitzky M, Langevitz P, Livneh A, Many A. Treatment of APLA Syndrome with low molecular weight heparin combined with aspirin. Arthritis Rheum 37 (suppl):S-325, 1994.

81.  Livneh A. Genetics and regulation of anti-DNA antibody idiotypes in lupus. Harefuah 127:495-499, 1994.

82.  Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum 37:1804-1811, 1994.

83.  Katz J, Nagler R, Barak S, Livneh A, Baum B, Atkinson J, Shemer J. Cytokines modulate interleukin-6 production by human salivary gland cell line. Cellular Immunol 159:211-219, 1994.

84.  Yakar S, Kaplan B, Livneh A, Martin B, Miura K, Ali-Khan Z, Shtrasburg S, Pras M. Direct evidence for SAA deposition in tissues during murine amyloidogenesis. Scand J Immunol 40:653-658, 1994.

85.  Maran R, Langevitz P, Gilburd B, Livneh A, Gazit E, Youinou P, Shoenfeld Y. The association between antiperinuclear factor (APF) and class II MHC HLA DR4/ DR1. Clin Experiment Rheumatol 12/S-11:S-108, 1994.

86.  Pras M, Zemer D, Langevitz P, A. Livneh A, Aksentijevitz I, Pras E, Kastner D. Familial Mediterranean fever. Localization of the gene and its origin. VI International Congress Inborn Errors of Metabolism. Book of Abstracts, 135, 1994.

87.  Yakar S, Livneh A, Kaplan B, Pras M. The molecular basis of reactive amyloidosis. Semin Arthritis Rheum 24:255-261, 1995.

88.  Bank I, Tanay A, Migdal A, Book M, Livneh A.V-gamma-9(-) /V-delta-2(+) cells from a patient  with Felty syndrome that exhibit aberrant response to triggering of the CD3 molecule can regulate immunoglobulin secretion by B cells. Clin Immunol Immunopathol 74:162-169, 1995.

89.  Langevitz P, Livneh A, Zemer D, Dolitzky M, Pras M. SLE in patients with familial Mediterranean fever (FMF). Lupus 4 Suppl 2:11, 1995.

90.  Langevitz P, Klein L, Livneh A, Bank I, Pras M. Pauzner R, Many A. Low dose IV cyclophosphamide in treatment of lupus nephritis. Lupus 4 Suppl 2: 65, 1995.

91.  Langevitz P, Livneh A, Bank I, Hassin S, Ohry A, Many A, Pras M. Transverse myelitis in SLE. The crucial role of delay in diagnosis. Lupus 4 Suppl 2:74, 1995.    

92.  Katz A, Eherenfeld M, Langevitz P, Livneh A, Bank I, Gur H, Pauzner H, Many A. Invasive aspergillosis in systemic lupus erythematosus. Lupus 4 Suppl 2:86, 1995.

93.  Pauzner R, Dolitzky M, Langevitz P, Livneh A, Many A. Treatment of APLA syndrome in pregnancy with low molecular weight heparin combined with aspirin. Lupus 4 Suppl 2:100, 1995.

94.  Livneh A, Langevitz P. Genetics and regulation of anti-DNA antibody idiotypes in lupus: Lessons from the 8.12 idiotype. Lupus 4 Supple 2:102, 1995.

95.  Braf A, Givol N, Langevitz P, Many A, Pras M, Livneh A. anti-insulin antibodies in systemic lupus erythematosus (SLE). Lupus 4 Supple 2:160, 1995.  

96.  Katz J, Barak S, Shemer S, Langevitz P, Livneh A. Black tongue associated with minocycline therapy. Arch Dermatol. 131: 620, 1995.

97.  Livneh A, Katz J, Zaks N, Langevitz P, Shemer J, Pras M. Arthropathy in recurrent aphthous stomatitis. Rheumatol in Europe24:100, 1995.

98.  Langevitz P, Bank I, Livneh A, Pras M. Long-term experience with minocycline in patients with resistant rheumatoid arthritis (RA). Rheumatol in Europe 24: 241, 1995.

99.  Yakar S, Kaplan B, German G, Livneh A, Katsutoshi M, Shtrasburg S, Pras M. Quantification of tissue amyloid content in AA amyloidosis by inhibition ELISA. Amyloid Int J Exp Clin Invest 2:167-172, 1995.

100. Pras E, Langevitz P, Livneh A, Zemer D, Padeh S, Pras M. Ethnical differences in the expression of familial Mediterranean fever (FMF). Arthritis Rheum. 38 Suppl: S-328, 1995.

101. Ehrenfeld M, Rachima C, Gur H, Livneh A, Bank I, Sadeh M, Langevitz P. Extremely high incidence of malignancies in patients with dermatomyositis. The VIth Northern Lights Neuroscience Symposium on Inflammatory Myopathies. Book of Abstracts. 14, 1995. 

102. Pras M, Sood R, Chen X, Langevitz P, Livneh A, Aksentijevitz I, Pras E, Balow J  Jr, Kastner D. Familial Mediterranean fever. Localization of the gene and its origin. The tenth congress of the international pediatric nephrology association. Book of Abstracts, C36, 1995.

103. Shtrasburg S, Livneh A, Gal R, Pras M. Extremely active murine amyloid enhancing factor. Clin Exp Rheumatol 14: 37:42, 1996.

104. Langevitz P, Livneh A, Bank I, Pras M. Minocycline in rheumatoid arthritis. Isr J Med Sci 32:327-330, 1996.

105. Pras M, Langevitz P, Livneh A, Zemer D. Vasculitis in familial Mediterranean fever. In: Ansell B, Bacon PA, Lie JT, Yazici H. Editors. The Vasculitides. Science and practice. Chapman & Hall, London. 412-416, 1996.

106. Yakar S, Livneh A, Pras M. Reactive amyloidosis: Advances in understanding its basic mechanisms. Harefuah. 130:688,693, 1996.

107. Livneh A, Zaks N, Katz J, Langevitz P, Shemer J, Pras M. Increased prevalence of joint manifestations in patients with recurrent aphthous stomatitis (RAS). Clin Exp Rheum. 14; 407-412, 1996.

108. Schulman S, Langevitz P, Livneh A, Martinowitz U, Seligsohn U, Varon D. Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus. Thromb Haemostas. 76: 344-346, 1996.

109. Livneh A, Drenth JPH, Klasen IS, Langevitz P, George J, Kastner DL, Pras M,  van der Meer JWM. Familial Mediterranean fever (FMF) and hyper- immunoglobulinemia D syndrome (HIDS) are two diseases with distinct features. Arthritis Rheum. 39 Suppl: S-49, 1996.

110. Kees S, Langevitz P, Zemer D, Padeh S, Pras M, Livneh A. Pericarditis as a manifestation of familial Mediterranean fever (FMF). Arthritis Rheum. 39 Suppl:S-49, 1996.

111. Livneh A, Langevitz P. Hyperimmunoglobulinemia D - a new periodic syndrome with features simulating familial Mediterranean fever. Harefuah. 131:283-284, 1996.

112. Haisraeli-Shalish M, Livneh A, Katz J, Doolman R, Sela B-A. Recurrent aphthous stomatitis and thiamine deficiency. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 82:634-636, 1996.

113. Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M. The changing face of familial Mediterranean fever. Semin Arthritis Rheum. 26:612-627, 1996.

114. Katz A, Ehrenfeld M, Livneh A, Bank I, Gur H, Pauzner R, Many A, Langevitz P. Aspergillosis in systemic lupus erythematosus. Semin Arthritis Rheum. 26:635-640, 1996.

115. Livneh A, Zaks N, Katz J, Langevitz P, Shemer J, Pras M. Reply to a letter by Weinberger on: Human lymphocyte antigen (HLA) B51 is more frequent in patients with recurrent aphthous stomatitis (RAS). Clin Exp Rheumatol 15:119, 1997.

116. Lidar T, Christian A, Yakar S, Langevitz P, Zeilig G, Ohry A, Bakimar R, Sorek H, Livneh A. Clinically insignificant (natural) autoantibodies against acetyl cholinesterase in the sera of patients with a variety of neurologic, muscular and autoimmune diseases. Immunol Lett. 55:79-84, 1997.

117. Ofri R, Nyska A, Linke RP, Shtrasburg S, Livneh A, Gal R. Systemic amyloidosis in a cheetah (Acinonyx Jubatus). Amyloid: Int J Exp Clin Invest. 4:98-103, 1997.

118. Livneh A, Renert A, Avishai O, Langevitz P, Gazit E. Lymphocytotoxic antibodies in Israeli patients with rheumatoid arthritis. Isr J Med Sci.33:30-35, 1997.

119. Shtrasburg S, Livneh A, Pras M, Weinstein T, Gal R. Detection of serum amyloid A (SAA) derived proteins in formalin fixed paraffin embedded tissues. Reliability of the method and expansion of its spectrum. Am J Clin Pathol. 108:289- 294, 1997.

120. Livneh A, Drenth JPH, Klasen IS, Langevitz P, George J, Shelton DA, Gumucio DL, Pras E, Kastner DL, Pras M, van der Meer JWM.  Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: Two diseases with distinct clinical, serologic and genetic features. J Rheumatol. 24:1558-63, 1997.

121. Schattner A, Hahn T, Lachmi M, Gurevitz A, Zemer D, Livneh A, Pras M. Cytokines in FMF: TNFa and C5a interaction in the pathogenesis of the inflammatory attacks and in diagnosis. In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean fever (FMF). Freund Publishing House Ltd., London. 11-6, 1997.

122. Alster Y, Loewenstein A, Lazar M, Langevitz P, Livneh A. Corneal wound healing in patients with familial Mediterranean fever treated with colchicine. In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean fever (FMF). Freund- Publishing House Ltd., London. 28-30, 1997.

123. Langevitz P, Amolsky D, Livneh A, Neumann L, Buskila D, Pras M. Ischemic heart disease in patients with familial Mediterranean fever. Role of colchicine. In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean fever (FMF). Freund Publishing House Ltd., London. 47-49, 1997.

124. Pras Er, Livneh A, Balow Jr. JE, Pras El, Kastner DL, Pras M, Langevitz P. Clinical heterogeneity in familial Mediterranean fever.  In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean Fever (FMF). Freund Publishing House Ltd., London. 62- 65, 1997.

125. Buskila D, Neumann L, Livneh A, Pras M,  Langevitz P. Fibromyalgia is an important contributor to quality of life in familial Mediterranean fever. In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean Fever (FMF). Freund Publishing House Ltd., London. 87-90, 1997.

126. Salai M, Langevitz P, Livneh A, Zemer D, Chechick A, Pras M. Total joint replacement in familial Mediterranean fever. In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean Fever (FMF). Freund Publishing House Ltd., London. 91-94, 1997.

127. Langevitz P, Livneh A, Zemer D, Shemer J, Pras M. The Spondyloarthropathies in patients with Familial Mediterranean Fever. In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean Fever (FMF). Freund Publishing House Ltd., London. 95-98, 1997.

128. Kees S, Langevitz P, Zemer D, Padeh S, Pras M, Livneh A. Pericarditis as a rare manifestation of familial Mediterranean fever. In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean Fever (FMF). Freund Publishing House Ltd., London.129-131, 1997.

129. Schwartz T, Langevitz P, Zemer D, Pras M, Livneh A. High frequency of Behcet's disease (BD) in familial Mediterranean fever (FMF). In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean Fever (FMF). Freund Publishing House Ltd., London. 148-150, 1997.

130. Zemer D, Shabtai M, Lustig S, Livneh A, Langevitz P, Migdal A, Padeh S, Pras M. Survival and outcome of FMF amyloidotic patients post renal transplantation. In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean Fever (FMF). Freund Publishing House Ltd., London. 185-150, 1997.

131. Gang N, Drenth JPH, Livneh a, Langevitz P, Zemer D, Brezniak N, Pras M, van der Meer JWM. Activation of the cytokine network in familial Mediterranean fever (FMF). In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean Fever (FMF). Freund Publishing House Ltd., London. 193-194, 1997.

132. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M. Establishment of a new set of criteria for the diagnosis of familial Mediterranean fever (FMF). In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean Fever (FMF). Freund Publishing House Ltd., London. 203-206, 1997.

133. Pras E, Langevitz P, Livneh A, Zemer D, Migdal A, Padeh S, Lubetzky A, Aksentijevich I, Centola M, Zaks N, Deng Z, Sood R, Kastner DL, Pras M. Genotype-phenotype correlation in familial Mediterranean fever (a preliminary report). In: Sohar E, Gafni J, Pras M. eds. Familial Mediterranean Fever (FMF). Freund Publishing House Ltd., London. 260-264, 1997.

134. Langevitz P, Livneh A, Zemer D, Shemer J, Pras M. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum. 27: 67- 72, 1997.

135. Kees S, Langevitz P, Zemer D, Padeh S, Pras M, Livneh A. Attacks of  pericarditis as a manifestation of familial Mediterranean fever. Q J Med 90:643- 647, 1997.

136. Balow Jr JE, Shelton DA, Orsborn A, Mangelsdorf M, Aksentijevich I, Blake T, Sood R, Gardner D, Liu R, Pras E, Levy EN, Centola M, Deng Z, Zaks N, Wood G, Chen X, Richards N, Shohat M, Livneh A, Pras M, Doggett NA, Collins FS, Liu PP, Rotter JI, Fischel-Ghodsian N, Gumucio D, Richards RI, Kastner DL. A high- resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype- sharing among ethnic groups. Genomics 44: 280-291, 1997.

137. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S,  Pras M. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 40:1879-1885, 1997.

138. Migdal A, Langevitz P, Padeh S, Pras E, Zemer D, Zaks N, Livneh A, Pras M. Ancient mutations in the sons of Shem cause familial Mediterranean fever. Harfuah.133; 372-374, 1997.

139. Buskila D, Zaks N, Neumann L, Livneh A, Greenberg S, Pras M, Langevitz P. Quality of life of patients with familial Mediterranean fever. Clin Exp Rheumatol 15; 55-60, 1997.

140. Levy Y, George J, Abraham A, Afek A, Livneh A, Shoenfeld Y. Subcutaneous T-cell lymphoma in a patient with rheumatoid arthritis not treated with cytotoxic agents. Clin Rheumatol. 16; 606-608, 1997.

141. Padeh S, Zemer D, Langevitz P, Livneh A, Migdal A, Pras M. Recurrent episodes of fever as the first manifestation of familial Mediterranean fever in young children. First International Conference on FMF. Book of Abstracts 46, 1997.

142. Tishler M, Maran R, Langevitz P, Livneh A, Gazit E, Gilburd B, Youinou P, Shoenfeld Y. Antiperinuclear factor - clinical, serological and genetic correlates in Israeli patients with rheumatoid arthritis. Rheumatol Int 17:141-143, 1997.

143. Salai M, Zemer D, Segal E, Corat A, Heyman Z, Davidson B, Langevitz P, Livneh A. Chronic massive knee effusion in familial Mediterranean fever. Semin Arthritis Rheum 27:169-172, 1997.

144. Pras E, Livneh A, Balow Jr JE, Pras E, Kastner DL, Pras M, Langevitz P. Clinical differences between north African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216-219, 1998.

145. Aharon A, Langevitz P, Maran R, Blank-Porat D, Shtrasburg S, Livneh A. Reactive amyloidosis in a patient with mycobacterium simiae pulmonary infection. Respiratory Med 92:123-124, 1988.

146. Rachima- Maoz C, Langevitz P, Livneh A, Blumstein Z, Sadeh M, Bank I, Gur H, Ehrenfeld M. High incidence of malignancies in patients with dermatomyositis and polymyositis:  An 11- year analysis. Semin Arthritis Rheum 27:319-324, 1988.

147. Apter S, Zaks N, Hardan I, Livneh A. Calcification in untreated non-Hodgkin mediastinal lymphoma. South Med J 91:212-213, 1998.

148. Shtrasburg S, Pras M, Brezniak N, Livneh A. Long term effects of amyloid enhancing factor (AEF). Clinical and experimental implications. Clin Exp Rheumatol 16:299-302, 1998.

149. Langevitz P, Livneh A, Zemer D, Pras M. Familial Mediterranean fever. In: Maddison PJ, Isenberg DA, Woo P, Glass DN. Editors. Oxford Textbook of Rheumatology. Oxford University Press. Second Edition. 1445-1450, 1998.

150. Pauzner R, Dolitzki M, Langevitz P, Livneh A, Many A. Treatment of APS in pregnancy with low molecular weight heparin combined with aspirin - A prospective study. Lupus 7 Supple 1:113, 1998.

151. Langevitz P, Livneh A, Dulitzki M, Pauzner R, Many A, Soriano D, Pras M. Outcome of pregnancy in three patients with primary antiphospholipid syndrome after stroke. Semin. Arthritis Rheum 28:26-30, 1998.

152. Livneh A, Langevitz P, Pras M. Criteria for the diagnosis of familial Mediterranean fever. Reply to the letter of Dr Tunca. Arthritis Rheum 41:1517-1518, 1998.

153. Brezniak N, Drenth JPH, Shtrasburg S, Langevitz P, Livneh A. IgD as a discriminator between Behcet's disease (BD) and hyper-IgD syndrome (HIDS). Ann. Rheum. Dis 57:255-256, 1998.

154. Apter S, Zemer D, Gayer G, Langevitz P, Amitai M, Swartz T, Atar E, Pras M, Livneh A. Computerized tomography (CT) features of amyloidosis of FMF. VIII International Symposium on Amyloidosis. 156, 1998.

155. Shtrasburg S, Livneh A, Pras M.  Induction of amyloidosis long after exposure to amyloid enhancing factor. VIII International Symposium on Amyloidosis. 158, 1998.

156. Pras E, Livneh A Langevitz P, Zemer D, Padeh S, Kastner D, Pras M. Homozygous M694V mutation of the MEFV gene carries a high risk of amyloidosis in patients with familial Mediterranean fever. VIII International Symposium on Amyloidosis. 158, 1998.

157. Langevitz P, Livneh A, Shinar Y, Sidi G, Kastner DL, Pras M, Pras E. Protracted febrile myalgia in familial Mediterranean fever: mutation analysis in the FMF gene (MEFV).  Arthritis Rheum 41 Suppl:S-232, 1998.

158. Shtrasburg S, Pras M, Brezniak N, Livneh A. Offspring of amyloidotic mice have no increased susceptibility to develop amyloidosis. In: Kyle RA, Gertz MA Eds. Amyloid and Amyloidosis 393-395, 1998.

159. Koren R, Livneh A, Shtrasburg S, Goldwasser B, Linke R, Gal R. Organ-limited amyloidosis of ejuculatory and deferent ducts and the seminal vesicles. In: Kyle RA, Gertz MA Eds. Amyloid and Amyloidosis 524-526, 1998.

160. Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, Pras E. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 6;1-6, 1999.

161. Sherer Y, Livneh A, Levy Y, Shoenfeld Y, Langevitz P. Dermatomyositis and polymyositis associated with the antiphospholipid syndrome – a novel overlap syndrome. J Autoimmunity, Supple;111, 1999.

162. Zaks N, Livneh A, Langevitz P, Bank I. Vasculitis following prostatectomy. J Autoimmunity, Supple; 76, 1999.

163. Amital H, Langevitz P, Levy Y, Afek A, Goldberg I, Pras M, Livneh A,  Shoenfeld Y. Valvular deposition of anti-phospholipid antibodies in the antiphospholipid syndrome. A clue to the origin of the disease. Clin Exp Rheumatol 17:99-102, 1999.

164. Gang N, Drenth JPH, Langevitz P, Zemer D, Brezniak N, Pras M, van der Meer JWM, Livneh A. Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 26:890-897, 1999.

165. Blank M,  Krause I,  Goldkorn T,  Praprotnik S, Livneh A, Langevitz P, Kaganovsky E, Morgenstern S, Cohen S, Barak V, Eldor A, Weksler B, Shoenfeld Y. Monoclonal anti- endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis Rheum 42: 1421-1432, 1999.

166. Shtrasburg S, Pras M, Brezniak N, Dolitzki M, Livneh A. Pregnancy and amyloidogenesis: I. Offspring of amyloidotic mice are not predisposed to develop amyloidosis. J Lab Clin Med 134:168-172, 1999. 

167. Padeh S, Brezniak N, Zemer D, Pras E, Livneh A, Langevitz P, Migdal A, Pras M, Passwell JH. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: Clinical characteristics and outcome. J Pediatr 135:98-101, 1999.

168. Fidder HH, Apter S, Langevitz P, Aviel-Ronen S, Bank I, Livneh A. P-Antineutrophil cytoplasmic antibodies associated vasculitis presenting with hemoptysis and a mediastinal mass. Chest 115:1473-1475, 1999.

169. Langevitz P, Livneh A, Padeh S, Zaks N, Shinar Y, Zemer D. Pras E, Pras M. Familial Mediterranean fever: new aspects and prospects at the end of the millenium. IMAJ 1:31-36, 1999.

170. Livneh A, Langevitz P, Pras M. Pulmonary associations in familial Mediterranean fever. Curr Opin Pulmon Med 5:326-331, 1999.

171. Katz J, Livneh A, Shemer J, Danon YL, Peretz B. Herpes simplex-associated erythema multiforme (HAEM): a clinical therapeutic dilemma. Pediatr Dent 21:359- 362, 1999.

172. Tamir N, Langevitz P, Zemer D, Pras E, Shinar Y, Padeh S, Zaks N, Pras M, Livneh A. Late onset familial Mediterranean fever (FMF): A subset with distinct clinical, demographic, and molecular genetic characteristics. Am J Med Genet 87:30-35, 1999.

173. Livneh A. Colchicine in FMF. Experience from treatment of 5000 patients. 2nd International Workshop on Hyper-IgD and Periodic Fever. December 1999.

174. Gang N, Langevitz P, Livneh A. Relapsing acute pancreatitis induced by re-exposure to the cholesterol lowering agent bezafibrate. Am J Gastroenterol. 94:3626-3628, 1999.

175. Pauzner R, Dulitzki M, Langevitz P, Livneh A, Kenett R, Many A. Warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Israel Rheumatology Society Annual Meeting. Book of Abstracts; 1999.

176. Bank I, Duvdevani M, Langevitz P, Pras M, Livneh A.  Increased proportion of gamma delta T cells in the peripheral blood of Israeli patients with Behcet’s disease.  Israel Rheumatology Society Annual Meeting. Book of Abstracts; 1999.

177. Livneh A. The role of diagnostic criteria in familial Mediterranean fever. Second International Conference in FMF. Book of Abstract; 37-41, 2000.

178. Livneh A. Episodic febrile syndrome (EFS) and episodic febrile auto-inflammatory diseases (EFAID).  Second International Conference in FMF. Book of Abstracts: 56-58, 2000.

179. Pras E, Shinar Y, Shoham N, Livneh A, Padeh S, Langevitz P, Pras M. Genotype – phenotype correlations in Israeli FMF patients. Second International Conference in FMF. Book of Abstract; 29-31, 2000.

180. Drenth PH, Poland D, van het Hof B, Livneh A, van Dijk W. Acute and chronic inflammation in FMF attacks and evidence for acute phase reaction in MEFV heterozygotes. Clin Exp Rheumatol 18: 278, 2000.

181. Padeh S, Shinar Y, Pras E, Zemer D, Livneh A, Langevitz P, Migdal A, Paswell JH, Pras M. Genotype-phenotype correlation in 75 pediatric familial Mediterranean fever patients. Clin Exp Rheumatol 18:283, 2000.

182. Kogan A, Shinar Y, Langevitz P, Zaks N, Padeh S, Livneh A, Pras M. Frequency of V726A, and E148Q mutations of the MEFV- gene among healthy Ashkenazi Jews in Israel. Clin Exp Rheumatol 18:285, 2000.

183. Shinar Y, Kogan A, Langevitz P, Padeh S, Pras E, Livneh A, Pras M. Frequency of V726A, E148Q and M694V mutations in the MEFV- gene among healthy North African and Iraqi Jews. Clin Exp Rheumatol 18:286, 2000.

184. Pras E, Shinar Y, Shoham N, Livneh A, Langevitz P, Kastner DL, Pras M. Genotype-phenotype assessment of  four common genotypes among patients with familial Mediterranean fever and possible effect of the R202Q polymorphism. Clin Exp Rheumatol 18:286, 2000.

185. Zaks N, Langevitz P, Kogan A, Padeh S, Shinar Y, Pras E, Livneh A, Pras M. Non-penetrant cases of double mutations in MEFV and mutations in phenotype II FMF patients. Clin Exp Rheumatol 18:287, 2000.

186. Langevitz P, Sidi G, Livneh A, Shinar Y, Pras M, Pras E. Protracted febrile myalgia of FMF: Mutation analysis and clinical features. Clin Exp Rheumatol 18:287, 2000.

187. Barzilai A, Langevitz P, Goldberg I, Kopolovic J, Livneh A , Pras M, Trau H. Erysipelas like erythema of familial Mediterranean fever: clinical pathological correlation. Clin Exp Rheumatol 18:292, 2000.

188. Langevitz P, Livneh A, Padeh S, Dolitzky M, Pras E, Pras M. Systemic lupus erythematosus, (SLE) and anti-phospholipid syndrome (APS) in FMF patients. Clin Exp Rheumatol 18:293, 2000.

189. Langevitz P, Chetrit A, Ariad S, Barchana M, Modan B, Livneh A, Pras M, Shemer S. Malignancies in patients with familial Mediterranean fever. Clin Exp Rheumatol 18:294, 2000.

190. Shtrasburg S, Pras M, Gal R, Livneh A. Inhibition of the second phase of amyloidogenesis in a mouse model by a single dose colchicine regimen. Clin Exp Rheumatol 18:296, 2000.

191. Apter S, Zemer D, Terhakopian A, Gayer G, Langevitz P, Amital M,  Schwartz T, Atar E, Hertz M, Pras M, Livneh A. Abdominal CT findings in nephrogenic amyloidosis of familial Mediterranean fever. Clin Exp Rheumatol 18:297, 2000.

192. Fidder HH, Langevitz P, Pras M, Livneh A. Crohn’s disease in patients with familial Mediterranean fever. Clin Exp Rheumatol 18:300, 2000.

193. Livneh A, Aksentijevich I, Langevitz P, Torosyan Y, Shinar Y, Pras E, Zaks N, Padeh S, Kastner DL, Pras M. Familial Mediterranean fever in carriers of a single mutated MEFV. An association with Behcet’s disease. Clin Exp Rheumatol 18:300, 2000.

194. Kogan A, Chetrit A, Lidar M, Langevitz P, Padeh S, Livneh A, Pras M.  FMF: characteristics of non-responders to colchicine treatment. Preliminary results. Clin. Exp. Rheumatol.18:301, 2000.

195. Drenth JPH, Livneh A. IgD in Behcet’s disease. Letter to the editor regarding the article by Sakane et al: Behcet’s disease. N Engl J Med. 342:588, 2000.

196. Apter S, Hertz M, Langevitz P, Gabriela G, Livneh A. Abdominal CT findings in nephropathic amyloidosis of familial Mediterranean fever. SGR and SUR meeting Book of Abstracts 70, 2000.

197. Sherer Y, Livneh A, Levy Y, Shoenfeld Y, Langevitz P. Dermatomyositis and polymyositis associated with the antiphospholipid syndrome – a novel overlap syndrome. Lupus 9:42-46, 2000.

198. Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behçet's disease in familial Mediterranean fever: Characterization of the association between the two diseases. Semin Arthritis Rheum 29:286-295, 2000.

199. Langevitz P, Livneh A, Bank I, Pras M. A preliminary risk-benefit assessment of minocycline in rheumatoid arthritis. Drug Safety 22:405-414, 2000.

200. Barzilai A, Langevitz P Goldberg I, Kopolovic J, Livneh A, Pras M, Trau H. Erysipelas-like erythema of familial Mediterranean fever: clinicopathological correlation. J Am Acad Dermatol 42:791-795, 2000.

201. Press J, Shinar Y, Langevitz P, Livneh A, Pras M. Familial Mediterranean fever in two Bedouin families: Mutation analysis and disease severity. Am J Med Genet 92: 247-249, 2000.

202. Sidi G, Shinar Y, Livneh A, Langevitz P, Pras M, Pras E. Protracted febrile myalgia of familial Mediterranean fever. Mutation analysis and clinical correlations. Scand J Rheumatol 29:174-176, 2000.

203. Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich I, Koziol DE, Kastner DL, Pras M, Pras E. Genotype-Phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 27:1703-1707, 2000.

204. Padeh S, Brezniak N, Zemer D, Pras E, Livneh A, Langevitz P, Migdal A, Pras M, Passwell JH. Response to the letter by Drenth JPH et al. HIDS and FHF are true periodic febrile syndromes. J Pediatr 137:439, 2000.

205. Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Bailliere’s Clin Rheumatol 14:477-498, 2000.

206. Pauzner R, Dulitzki M, Langevitz P, Livneh A, Kenett R, Many A. Warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. J Autoimmunity 15: A70, 2000.

207. Sherer Y, Salomon O, Livneh A, Pras M, Langevitz P. Thromboembolism in a patient with transient eosinophilia and thrombocytopenia. Clin Lab Haem 22:247-249, 2000.

208. Livneh A, Shtrasburg S, Langevitz P. Regression of nephrotic syndrome in amyloidosis of familial Mediterranean fever following colchicine treatment. Nephrol Dial Transplant 15:1713-1714, 2000.

209. Shtrasburg S, Pras M, Dolitzky M, Pariente C, Gal R, Livneh A. Pregnancy and amyloidosis: II. Suppression of amyloidogenesis during pregnancy. J Lab Clin Med 136:314-319, 2000.

210. Pras E, Neumann R, Bank I, Livneh A, Levy Y, Zandman-Goddard G, Langevitz P. Ocular manifestations of Wegener’s granulomatosis patients: 15 years experience in the Sheba Medical Center. IMAJ 2, Supple2: 38, 2000.

211. Lidar M, Shinar Y, Chetrit A, Litvak I, Langevitz P, Pras M, Livneh A. Clinical and genetic characteristics of familial Mediterranean fever patients not responding to colchicine. IMAJ 2, Supple2; 36, 2000.

212. Shinar Y, Livneh A, Pinhasov A, Zeitoun I, Achiron A. The natural history of multiple sclerosis and mutations in the familial Mediterranean fever gene in Sephardi Jews. Neuroscience Lett Supple 55:S51-S52, 2000.

213. Apter S, Zemer D, Terhakopian A, Gayer  G, Langevitz P, Amitai M, Schwartz T, Atar E, Hertz M, Pras M, Livneh A. Abdominal CT findings in nephropathic amyloidosis of familial Mediterranean fever. Amyloid 8:58-64, 2000.

214. Langevitz P, Livneh A, Neumann L, Buskila D, Shemer J, Amolsky D, Pras M. Prevalence of ischemic heart disease in patients with familial Mediterranean fever. IMAJ 2:9-12, 2000.

215. Langevitz P, Livneh A, Neumann L, Buskila D, Shemer J, Pras M. Atherosclerosis and familial Mediterranean fever. In: Shoenfeld Y, Harats D, Wick G. Atherosclerosis and Autoimmunity. Elsevier Amsterdam 335-337, 2001.

216. Livneh A, Aksentijevitch I, Langevitz P, Torosyan Y, G-Shoham N, Shinar Y, Pras E, Zaks N, Padeh S, Kastner D, Pras M. Single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behcet's disease (FMF-BD). Eur J Hum Genet 9:191-196, 2001.

217. Poland DCW Drenth JPH, Rabinovitz E, Livneh A, Bijzet J, van het Hof B, van Dijk W. Specific glycosilation of alpha 1- acid glycoprotein characterizes familial Mediterranean fever and obligatory carriers of MEFV. Ann Rheum Dis 60:777-780, 2001. 

218. Lidar M, Braf A, Givol N, Langevitz P, Pauzner R, Many A, Livneh A. Anti-insulin antibodies and the natural autoimmune response in systemic lupus erythematosus. Lupus 10:81-86, 2001.

219. Kogan A, Shinar Y, Lidar M, Revivo A, Langevitz P, Padeh S, Pras M, Livneh A. Common MEFV mutations among Jewish ethnic groups in Israel: High frequency of carrier and phenotype III states and absence of a perceptible biological advantage of the carrier state. Am J Med Genet 102:272-276, 2001.

220. Shtrasburg S, Pras M, Gal R, Salai M, Livneh A. Inhibition of the second phase of amyloidogenesis in a mouse model by a single dose colchicine regimen. J Lab Clin Med 138:107-111, 2001.

221. Shtrasburg S, Pras M, Gal R, Livneh A. The second phase of murine amyloidosis is suppressed by colchicine. In: Bely M, Apathy A, Eds. Amyloid and Amyloidosis Hungarian Academy of Sciences. 68, 2001.

222. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. Contribution of genotypes at the SAA1 locus to amyloidosis and disease severity in patients with familial Mediterranean fever. In: Bely M, Apathy A, Eds. Amyloid and Amyloidosis Hungarian Academy of Sciences. 110, 2001.

223. Shtrasburg S, Gal R, Perl S, Koren R, Pras M, Livneh A. An ancillary tool for the diagnosis of animal AA amyloidosis. In: Bely M, Apathy A, Eds. Amyloid and Amyloidosis Hungarian Academy of Sciences. 149, 2001.

224. Rabinovitz E, Livneh A, Langevitz P, Shinar E, Shinar Y. A gender related association between MEFV mutations and development and severity of rheumatoid arthritis. Israel Rheumatology Society Annual Meeting. Book of Abstracts 2001.

225. Barash J, Pirogovski A, Livneh A, Brezniak N, Dror Y, Hahn T. Colchicine treatment in FMF: An indirect effect on invitro serum amyloid A secretion via leukocyte derived factors. Clin Exp Rheumatol 19 (Suppl. 24); S-76, 2001.

226. Pauzner R, Dulitzki M, Langevitz P, Livneh A, Kenett R, Many A. Low molecular Weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 86:1379-1384, 2001.

227. Livneh A. Shtrasburg S, Martin BM, Baniel J, Gal R, Pras M. Light chain amyloidosis of the urinary bladder. A site restricted deposition of an externally produced immunoglobulin. J Clin Pathol 54:920-923, 2001.

228. Ben-Horin S, Luria D, Glikson M, Livneh A, A nerve-racking syncope. IMAJ 4:142-145, 2002.

229. Fidder HH, Chowers Y, Lidar M, Langevitz P, Bar-Meir S, Livneh A. Crohn's disease in patients with familial Mediterranean fever. Gastroenterology 122;A-608, 2002

230. Sherer Y, Dulitzki M, Levy Y, Livneh A, Shoenfeld Y, Langevitz P. Successful pregnancy outcome in a patient with Gaucher’s disease and antiphospholipid syndrome. Ann Hematol. 81:161-163, 2002.

231. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 10:145-149, 2002.

232. Shtrasburg S, Pras M, Lidar M, Livneh A. Extremely high dose pravastatin may suppress amyloidogenesis in a mouse model. Ann Rheum Dis 61:572, 2002.

233. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. Male gender increases susceptibility to amyloidosis in FMF patients homozygous for the M694V-MEFV mutation. Eur J Hum Genet 10, Supple1:140, 2002.

234. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 10, Supple1:140, 2002.

235. Sherer Y, Hassin S, Shoenfeld Y, Levy Y, Livneh A, Ohry A, Langevitz P. Transverse myelitis in patients with antiphospholipid antibodies – the importance of early diagnosis and treatment. Clin Rheumatol 21:207-210, 2002.

236. Leiba M, Zeligsohn U, Sidi Y, Haratz D, Sela B, Gur H, Livneh A, Ehrenfeld M. Variables associated with vascular thrombosis in Behcet’s disease. 10th international conference on Behcet’s disease, Book of Abstracts; 62, 2002.

237. Lidar M, Pras M, Langevitz P, Livneh A. Thoracic and lung involvement in familial Mediterranean fever. Clin Chest Med 23:505-511, 2002.

238. Rabinovitz E, Livneh A, Langevitz P, Shinar E, Zaks N, Shinar Y. Mediterranean fever gene (MEFV) mutations and rheumatoid arthritis: A severe combination. Clin Exp Rheumatol 20, Supple 26; S-73, 2002.

239. Shinar Y, Livneh A, Villa Y, Pinhasov A, Zeitoun I, Achiron A. MEFV mutations and autoimmune diseases: A severe combination. Clin Exp Rheumatol 20, Supple 26; S-75, 2002.

240. Shtrasburg S, Pras M, Dolitzki M, Pariente C, Gal R, Livneh A. Increased propensity for amyloidogenesis in male mice. Clin Exp Rheumatol 20, Supple 26; S-79, 2002.

241. Bank I Duvdevani M, Livneh A. Gamma-delta TCR in FMF and BD. Clin Exp Rheumatol 20, Supple 26; S-80, 2002.

242. Langevitz P, Zandman-Goddard G, Blank M, Pras M, Livneh A, Shoenfeld Y. SLE in FMF. The possible role of serum amyloid P (SAP). Clin Exp Rheumatol 20, Supple 26; S-82, 2002.

243. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. Susceptibility to amyloidosis, influenced by genotypes at both the MEFV and the SAA1 loci, is further modified by effects of gender coupled with articular manifestations in patients with FMF. Clin Exp Rheumatol 20, Supple 26; S-84, 2002.

244. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. FMF in the Middle East: MEFV mutant alleles are differentially distributed among diverse ethnic groups and differentially contribute to the clinical profile of the disease. Clin Exp Rheumatol 20, Supple 26; S-84, 2002.

245. Osban J, Knowlton N, Wallis G, Shinar Y, Livneh A, Centola M. A simple new FMF mutation detection method. Clin Exp Rheumatol 20, Supple 26; S-85, 2002.

246. Mor A, Zaks N, Shinar Y, Langevitz P, Lidar M, Livneh A. A novel severity scoring system for FMF. Clin Exp Rheumatol 20, Supple 26; S-88, 2002.

247. Lidar M, Scherrmann JM, Chetrit A, Niel E, Gershoni R, Livneh A. Clinical, Genetic, Pharmacokinetic and socioeconomic characterization of colchicines nonresponsiveness in FMF. Clin Exp Rheumatol 20, Supple 26; S-88, 2002.

248. Lidar M. Kedem R, Mor A, Levartovski D, Langevitz P, Livneh A. Arthritis as the sole episodic manifestation of  FMF. Clin Exp Rheumatol 20, Supple 26; S-88, 2002.

249. Zaks N, Tokov I, Shinar Y, Lidar M, Langevitz P, Livneh A. Parameters associated with a prolonged delay (>10 years) in the diagnosis of FMF. Clin Exp Rheumatol 20, Supple 26; S-93, 2002.

250. Lidar M, Kedem R, Langevitz P, Zaks N, Pras M, Livneh A. Intravenous colchicines treatment for FMF patients unresponsive to oral colchicines therapy. Clin Exp Rheumatol 20, Supple 26; S-105, 2002.

251. Leiba M, Zeligsohn U, Sidi Y, Haratz B, Sela B, Gur H, Livneh A, Ehrenfeld M. Variables associated with vascular thrombosis in Behcet’s disease. ISR meeting. Book of abstracts, 2002.

252. Molad Y, Fridenberg A, Bloch K, Langevitz P, Mukamel M, Sulkes J, Pras M, Livneh A. Neutrophil surface expression of B2-integrin and L-selectin in acute attacks of familial Mediterranean fever: evidence for a non-chemoattractant receptor-mediated stimuli. ISR meeting. Book of Abstracts, 2002.

253. Lidar M, Zlotogorski A, Zandman-Goddard G, Livneh A, Zaks N, Langevitz P. Destructive Arthritis in a patient with Haim Munk syndrome. Arthritis Rheum 46 Supple: S163, 2002.

254. Molad Y, Fridenberg A, Bloch K, Langevitz P, Mukamel M, Sulkes J, Pras M, Livneh A. Neutrophil integrin upregulation in acute attacks of familial Mediterranean fever (FMF) Arthritis Rheum 46 Supple; S379, 2002.

255. Fidder HH, Chowers Y, Lidar M, Sternberg M, Langevitz P, Livneh A. Crohn's disease in patients with familial Mediterranean fever. Medicine 81:411-416, 2002.

256. Lidar M, Weiss P, Yosepovich A, Langevitz P, Livneh A. Sclerosing cholangitis associated with systemic sarcoidosis. J Clin Gastroenterol 36:84-85, 2003.

257. Padeh S, Shinar Y, Pras E, Zemer D, Langevitz P, Pras M, Livneh A. Clinical and diagnostic value of genetic testing in 216 Israeli children with familial Mediterranean fever. J Rheumatol 30:185-190, 2003.

258. Bank I, Duvdevani M, Livneh A. Expansion of gamma delta T cells in Behcet’s disease: role of disease activity and microbial flora in oral ulcers. J Clin Lab Med. 141:33-41, 2003.

259. Knappskog PM, Majewski J, Livneh A, Nilsen PTE, Bringsli JSB, Ott Jurg Boman H. Cold-induced sweating syndrome is caused by mutations in the CRLF1 gene. Am J Hum Genet. 72:375-383, 2003.

260. Gershoni-Baruch R, Brik R, Lidar M, Shinawi M, Livneh A. Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation. J Rheumatol 30:308-312, 2003.

261. Langevitz P, Livneh A. Third international conference on familial Mediterranean fever and other hereditary inflammatory disorders. IMAJ 5:148-150, 2003.

262. Leibovitch I, Alster Y, Scherrmann JM, Azmon B, Barequet IS, Livneh A, O’Brien TP, Moshe L Loewenstein A. Colchicine in tear fluid of patients with familial Mediterranean fever. Cornea 23:191-193, 2003.

263. Gershoni-Baruch R, Brik R, Zaks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 48:1149-1155, 2003.

264. Shinar Y, Livneh A, Villa Y, Pinhasov A, Zeitoun I, Kogan A, Achiron A. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immunity 4;197-203, 2003.

265. Livneh A. Familial Mediterranean fever and Behcet’s disease. Clin Exp Rheumatol 21;266, 2003.

266. Touitou I, Ben-Chetrit E, Gershoni-Baruch R, Grateau G, Kastner DL, Kone-Paut I, Livneh A, Manna R, Mansour I, Ozdogan H, Ozen S, Sarkisian T, Tunca M, Yalcinkaya F. Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever. Blood 102;409, 2003.

267. Ben-Horin S, Bardan E, Barshack I, Zaks N, Livneh A. Cholesterol crystal embolization to the digestive system: characterization of a common, yet overlooked presentation of atheroembolism. Am J Gastroenterol 98:1471-1479, 2003.

268. Leibovitch I, Alster Y, Lazar M, Langevitz P, Livneh A, Loewenstein A. Corneal wound healing in a patient treated with colchicine for familial Mediterranean fever (FMF). Rheumatology 42:1021-1022, 2003.

269. Zaks N, Shinar Y, Padeh S, Lidar M, Mor A, Tokov I, Pras M, Langevitz P, Pras E, Livneh A. Analysis of the three most common mutations in 412 patients with familial Mediterranean fever. IMAJ 5:585-588, 2003.

270. Ben-Horin S, Motro M, Guranda L, Ziskind Z. Livneh A. A giant left ventricular pseudoaneurysm as a late sequela of aortic valve endocarditis. Am J Med Sci. 326:375-377, 2003.

271. Lidar M, Kedem R, Langevitz P, Pras M, Livneh A. Intravenous colchicine for the treatment of familial Mediterranean fever (FMF) patients unresponsive to oral colchicine. J Rheumatol. 30:2620-2623, 2003.

272. Mor A, Gal R, Livneh A. Abdominal and digestive system associations of familial Mediterranean fever. Am J Gastroenterol. 98:2594-2604, 2003.

273. Tweezer-Zaks N, Langevitz P, Livneh A. Long term follow up needed to define role of infliximab in treatment of renal amyloidosis. Arthritis Rheum (Letter) 48:3298-3299, 2003.

274. Lidar M, Scherrmann JM, Shinar Y, Chetrit A, Niel E, Gershoni-Baruch R, Langevitz P, Livneh A. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic and socioeconomic characterization. Semin Arthritis Rheum. 33:273-282, 2004.

275. Mor A, Mekori YA, Livneh A. Familial Mediterranean fever and celiac sprue. Are they related? Clin Exp Rheumatol. (Letter) 22:82, 2004.

276. Koukoui L, Blau A, Kopolovic J, Pras M, Livneh A.  A possible favorable effect of colchicine in IgA nephropathy in a carrier of a MEFV mutation. Clin Nephrol 62:226-228, 2004.

277. Shtrasburg S, Pras M, Dulitzky M, Pariente C, Gal R, Mor A, Livneh A. Lower propensity for amyloidogenesis in female mice. 10th Int'l Symposium on Amyloid and Amyloidosis, Book of Abstracts, p. 57, 2004.

278. Shtrasburg S, Pras M, Pariente C, Gal R, Livneh A. Hydrocortisone suppresses the second phase of amyloidogenesis in a mouse model. 10th Int'l Symposium on Amyloid and Amyloidosis, Book of Abstracts, p. 58, 2004.

279. Livneh A, Pras M, Langevitz P. Familial Mediterranean fever. In: Isenberg DA, Maddison PJ, Woo P, Glass D, Breedveld F. Oxford Textbook of Rheumatology. 3rd edition. Oxford University Press. London. 1020-1025, 2004.

280. Bentancur AG, Livneh A, Naveh N, Sela B. Leukotriene B4, acute abdominal familial Mediterranean fever and acute abdominal pain from other etiologies. Ann Emerg Med 44:S-15, 2004.

281. Ben-Horin S, Portnoy O, Pauzner R, Livneh A. Localized pericardial inflammation  in systemic lupus erythematosus. Clin Exp Rheumatol 22:483-484, 2004.

282. Molad Y, Fridenberg A, Bloch K, Langevitz P, Mukamel M, Sulkes J, Pras M, Livneh A. Neutrophil adhesion molecule expression in familial Mediterranean fever: discordance between the intravascular regulation of beta-2-integrin and L-selectin expression in acute attack. J Investig Med 52:58-61, 2004.

283. Leiba M, Seligson U, Sidi Y, Harats D, Sela B-A, Griffin JH, Livneh A, Rosenberg N, Gelernter MA, Gur H, Ehrenfeld M. Thrombophilic factors are not the leading cause of thrombosis in Behcet's disease. Ann Rheum Dis 63:1445-1449, 2004.

284.Tweezer-Zaks N, Langevitz P, Livneh A. New pieces in the puzzle of auto inflammatory disorders. IMAJ. 6:103-106, 2004.

285. Dember L, Gorevic P, Benson M and the FAST Group. GAG mimetics for systemic amyloidosis: design and progress of an international multi-center trial of NC-503 for amyloid A (AA) amyloidosis. ASN, 2004.

286. Kaplan B, Martin BM, Livneh A, Pras M, Gallo GR. Biochemical subtying of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data. Am J Clin Pathol 121:794-800, 2004.

287. Shtrasburg S, Pras M, Dulitzky M, Pariente C, Gal R, Mor A, Livneh A. Increased propensity for amyloidosis in male mice. Clin Exp Rheumatol 22:421-426, 2004.

288. Bentancur AG, Naveh N, Lancri J, Selah B-A, Livneh A. Urine leukotriene B4 in familial Mediterranean fever. Clin Exp Rheumatol 22(Suppl34):S56-S58, 2004.

289. Lidar M, Kedem R, Mor A, Levartovski D, Langevitz P, Livneh A. Arthritis as the sole episodic manifestation of FMF. The Annual Israel Society of Rheumatology Meeting. Book of Abstracts. 2004.

290. Fidder H, Shinar Y, Chowers Y, Ackerman Z, Dresner-Pollakm R, Bar-Meir S, Livneh A. The familial Mediterranean fever gene as a modifier of Crohn's disease. The Annual Israel Society of Rheumatology Meeting. Book of Abstracts. 2004.

291. Shinar Y, Menasherov S, Kuchuk I, Kolet M, Pras E, Langevitz P, Livneh A. A novel Persian Jewish FMF mutation. The Annual Israel Society of Rheumatology Meeting. Book of Abstracts. 2004.

292. Dudkiewicz I, Cohen I, Horowitz S, Regev S, Perelman M, Chechik A, Langevitz P, Shtrasburg S, Livneh A, Salai M.   Colchicine inhibits heterotopic ossification: experimental study in rabbits. Isr Med Assoc J 7:31-34, 2005.

293. Fidder H, Chowers Y, Ackerman Z, Dresner-Pollak R, Bart J, Crusius A, Livneh A, Bar-Meir S, Avidan B, Shinar Y. The familial Mediterranean fever (MEFV) gene as a modifier of Crohn's disease. Am J Gastroenterol 100:338-343, 2005. 

294. Ben-Horin S, Shinfeld A, Chetrit A, Kachel E, Livneh A. The normal composition of pericardial fluid – implication for diagnosis of pericardial effusions. Israel Society of Internal Medicine Meeting , 2005.

295. Shtrasburg S, Gal R, Gruys E, Perl S, Martin BM, Kaplan B, Koren R, Nyska A, Pras M, Livneh A. An ancillary tool for the diagnosis of AA amyloidosis in a variety of domestic and wild animals. Vet Pathol 42:132-139, 2005.

296. Shtrasburg S, Pras M, Dulitzky M, Pariente C, Gal R, Mor A, Livneh A. Lower propensity for amyloidosis in female mice. In: Gratear G, Kyle RA, Skinner M, Eds. Amyloid and Amyloidosis. CRC Press, New York. pp.238-240, 2005.

297. Shtrasburg S, Pras M, Pariente C, Gal R, Livneh A. Hydrocortisone suppresses the second phase of amyloidogenesis in a mouse model. In: Gratear G, Kyle RA, Skinner M, Eds. Amyloid and Amyloidosis. CRC Press, New York. pp.256-257, 2005.

298. Lidar M, Kedem R, Mor A, Levartovski D, Langevitz P, Livneh A. Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol 32:859-862, 2005.

299. Kaplan B, Martin BM, Cohen HI, Manaster J, Kassif Y, Rehany U, Livneh A. Primary local orbital amyloidosis: biochemical identification of the immunoglobulin light chain kIII subtype in a small formalin fixed, paraffin wax embedded tissue sample. J Clin Pathol 58:539-542, 2005.

300. Ben-Horin S, Shinfeld A, Kachel E, Chetrit A, Livneh A. The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions. Am J Med 118:636-640, 2005.

301. Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M, Shinar Y. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 64:1009-1014, 2005.

302. Lidar M, Tokov I, Chetrit A, Zaks N, Langevitz P, Livneh A. Diagnosis delay in familial Mediterranean fever (FMF): Social and gender gaps disclosed. Clin Exp Rheumatol 23:357-363, 2005.

303. Bentancur AG, Naveh N, Lancri J, Selah B-A, Shtrasburg S, Livneh A. Urine leukotriene B4 in familial Mediterranean fever and other forms of right lower abdominal pain. Acad Emerg Med 12:671-674, 2005.

304. Hazenberg BPC, Bijzet J, Butrimiene I, Livneh A, et al. Impact of fibrillex an anti-amyloid product on amyloid A (AA) protein content in abdominal fat tissue biopsies from patients with AA amyloidosis: results from a pivotal international trial. Annual European Congress of Rheumatology (EULAR 2005) Book of Abstracts 223, 2005.

305. Gorevic PD, Livneh A, Dember LM, Skinner M, et al. Long term safety and efficacy of fibrillex, an anti-amyloid product, as a treatment for amyloid A (AA) amyloidosis: interim analysis of the open-label extension of pivotal FAST trial. Annual European Congress of Rheumatology (EULAR 2005) Book of Abstracts 564, 2005.

306. Mor A, Shinar Y, Zaks N, Langevitz P, Chetrit A, Shtrasburg S, Rabinovitz E, Livneh A. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis rheum 35:57-64, 2005

307. Tweezer-Zaks N, Langevitz P, Rabinovich E, Livneh A. Pulmonary manifestations in familial Mediterranean fever. In: Sharma ed. Tropical Lung Diseases. Marcel Dekker Inc., New York Accepted. 367-376, 2005.

308. Tweezer-Zaks N, Marai I, Livneh A, Bank I, Langevitz P. Autoimmune phenomena following prostatectomy. Isr Med Assoc J. 7:575-577. 2005. 

309. Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC, Zanni D, Penco S, Boiani E, Ghirardello A, Caforio ALP, Bergantin A, Tombini V, Moreo A, Ashtamkar L, Doria A, Shoenfeld Y, Livneh A. Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations, and disease evolution in a large cohort of Caucasian patients. Lupus 14:670-674, 2005.

310. Kaplan B, Martin BM, Livoff A, Yeremenko D, Livneh A, Cohen HI Gastrointestinal β2 microglobulin amyloidosis in hemodialysis patients: biochenical analysis of amyloid proteins in small formalin-fixed paraffin-embedded tissue specimens. Modren Pathol 18:1610-1617, 2005.

311. Lidar M, Livneh A. The arthritis of familial Mediterranean fever. J Rheumatol 32:2278, 2005.

312. Gershoni-Baruch R, Peretz Y, Lidar M, Dagan E, Schermann J-M, Livneh A. The influence of polymorphisms in MDR1 on colchicine unresponsiveness in familial Mediterranean fever. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 23, 2005.

313. Livneh A, Gul A, Ozdogan H, Direskeneli H, Hawkins PN, Lachmann HJ, Dember LM, Skinner M, Hachulla E, Merlini G, Obici L, Benson MD, Gorevic PD, Hauck W, Garceau D. The effect of NC-503 (Fibrillex; 1,3-propane disulfonate; 1,3-PDS) in the treatment of amyloid A (AA) amyloidosis in patients with FMF: a subgroup analysis of an international randomized placebo controlled study.The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 24, 2005.

314. Berkun Y, Padeh S, Reichman B, Zaks N, Rabinovitz E, Doron A, Livneh A. Serum amyloid A level as a tool in the diagnosis and treatment of familial Mediterranean fever. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 47, 2005.

315. Koukoui L, Kopolovic J, Blau A, Ben-David A, Lotan D, Shaked M, Shinar Y, Langevitz P, Livneh A. MEFV mutation analysis in patients with IgA nephropathy and other types of glomerulonephritis. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 48, 2005.

316. Rabinovich E, Langevitz P, Leiba M, Shinar Y, Livneh A. Common FMF alleles increase the risk for developing vascular Behcet’s disease. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 48, 2005.

317. Shtrasburg S, Pras M, Priente C, Gal R, Livneh A. A variety of corticosteroids suppress the second phase of amyloid formation in mice. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 75, 2005.

318. Lidar M, Langvitz P, Zaks N, Doron A, Rabinovich E, Livneh A. Appendectomy in familial Mediterranean fever patients. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 75-76, 2005.

319. Leibovitz A, Lidar M, Baumoehl Y, Livneh A, Segal R. Colchicine therapy and the cognitive status of elderly patients with familial Mediterranean fever. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 76, 2005.

320. Lidar M, Yaqubov M, Zaks N, Ben-Horin S, Langvitz P Livneh A. The prodrome as a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 76, 2005.

321. Tweezer-Zaks N, Rabinovitz E, Livneh A. Interferon alpha (IFN) for the treatment of FMF attacks. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 83, 2005.

322. Tweezer-Zaks N, Doron-Libner A, Ben-Horin S, Weiss P Livneh A. Cryptogenic cirrhosis in a cohort of patients with familial Mediterranean fever. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 84, 2005.

323. Doron-Libner A, Tweezer-Zaks N, Barzilai A, Livneh A, Langevitz .  Erysipelas like erythema as the first manifestation of familial Mediterranean fever. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 84, 2005.

324. Shinar Y, Brucato A, Ashtamker L, Robbiolo L, Brambilla L, Livneh A. Idiopathic recurrent acute pericarditis: Lack of familial Mediterranean fever mutations. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 85, 2005.

325. Shinar Y, Menasherow S, Kuchuk I, Kolet M, Langevitz P, Pras E, Livneh A. A novel, Irenian Jewish mutation in the B30.2 domain of the FMF gene: clinical and conformational significance. The Forth International Congress on Systemic Autoinflammatory Diseases. Book of Abstracts 85, 2005.

326. Livneh A. Diagnosis of FMF: a glance at the current status. Presented at the Forth International Congress on Systemic Autoinflammatory Diseases 2005.

327. Livneh A. Familial Mediterranean fever. The Tel-Hashomer experience. Presented at the Forth International Congress on Systemic Autoinflammatory Diseases 2005.

328. Gorevic PN Hawkins PN, Butrimiene I, Livneh A, et al. Treatment of AA amyloidosis: Results of a multi-center, randomized, placebo- controlled trial with 1,3-propanedisulfonate (1,3 PDS; NC 503).  ACR/ARHP annual scientific meeting program book supplement. 70, 2005.

329. Rabinovich E, Shinar Y, Lidar M, Leiba M, Langevitz P, Livneh A. Common FMF alleles as a risk factor and phenotype modifier in Behcet’s disease. The Israel Society of Rheumatology Annual Meeting. Book of Abstracts 20, 2005.

330. Ben-Horin S, Bank I, Guetta V, Livneh A. Large symptomatic pericardial effusion as the presentation of unrecognized cancer. A study in 173 consecutive patients undergoing pericardiocenthesis. Medicine 85:49-53, 2006.

331. Kaplan B, Martin BM, Livneh A, Pras M, Gallo G. Biochemical micro-techniques in the diagnosis and classification of amyloidosis. Curr Pharmaceutic Anal 2:45-52, 2006.

332. Rabinovich E, Harats D, Luvish T, Yaron P, Issahar Ben-Dov, Livneh A. MEFV confers protection against asthma in Iraqi Jewish population. Presented at the Annual Meeting of the Israel Association of Pulmonology, 2006.

333. Lidar M, Yaqubov M, Zaks N, Ben-Horin S, Langevitz P, Livneh A. The Prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol 33: 1069-1092, 2006.

334. Livneh A. Environmental, genetic and age related factors in AA amyloidosis. Presented at the NIH Symposium on Amyloidosis Research. 2006.

335. Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello A, Doria A, Shinar Y, Livneh A, et al. Long term outcomes in difficult- to-treat patients with recurrent pericarditis. J Cardiol 98:267-271, 2006.

336.Hazenberg BPC, Hawkins PN, Butrimiere I, Lesnayak O, Livneh A,.Nasonov EL, Filipowicz-Sosnowska A,  Marlini G et.al. Treatment for amyloid A (AA) amyloidosis with eprodisate disodium: 2 year results of efficacy and safty from A multi-center international trial. Ann Rheum Dis (Suppl II) 65: 101, 2006.

337. Leibovitz A, Lidar M, Baumoehl Y, Livneh A, Segal R. Colchicine therapy and the cognitive status of elderly patients with familial Mediterranean fever. Isr Med Assoc J 8:469-472, 2006.

338. Kaplan B, Livneh A, Gallo G. Charge heterogeneity of in vivo immunoglobulin light chain amyloid versus  charge homogeneity of nonamyloid light chain deposits. FASEB Summer Research Conference. 2006.

339. Livneh A. Amyloidosis of familial Mediterranean fever (FMF)-insights to FMF phenotype II. Harefuah 145:743-745, 782, 2006.

340. Lidar M, Kedem R, Hazenberg B, Hauck W, Livneh A. Amyloid A protein in aspirated fat tissue of patients with secondary amyloidosis correlates with deteriorating  creatinine clearance but not with proteinuria. Amyloid 13 (Supple 1): 41, 2006.

341. Kaplan B, Livneh A, Gallo G. Charge differences of deposits in AL and NALCDD. Amyloid 13 (Supple 1): 35, 2006. 

342. Shinar Y, Kaplan B, Avisar C, Livneh  A. A novel transthyretin mutation in an Israeli patient with amyloidodotic neuropathy localizes to a 3D mutation hotspot. Amyloid 13 (Supple 1): 58, 2006.

343. Shtrasburg S, Lidar M, Pras M, Gal R, Livneh. A. The effect of a variety of anti-inflammatory drugs on murine amyloidogenesis. Amyloid 13 (Supple 1): 58, 2006.

344.Tweezer-Zaks N, Ben-Horin S, Schiby G, Bank I, Levi Y, Livneh A, Langevitz P. Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association. Am J Med Sci 332: 308-313, 2006.

345. Livneh A, Gorevic PD, Direskeneli H, Gul A, Ozdogan H, Hawkins PN et al. Response observed during treatment for amyloid A (AA) amyloidosis with eprodisate after 2 years in patients with familial Mediterranean fever in comparison to patients with rheumatoid arthritis. Arthritis Rheum 54, (Supple):  S142, 2006.

346. Berkun Y, Padeh  S, Reichman B, Zaks N, Rabinovitz E, Doron A, Livneh A. Serum amyloid A as a tool in the diagnosis and treatment of familial Mediterranean fever. Arthritis Rheum 54, (Supple): S143, 2006.

347. Lidar M, Zandman-Goddard G, Zaks N, Shinar Y, Livneh A, Langevitz P. Systemic lupus erythematosus and familial Mediterranean fever: a possible negative association between the two disease entities. Report of four cases and review of the literature. Arthritis Rheum 54, (Supple):S144, 2006.

348. Gorevic PD, Hawkins PN, Livneh A, Butriemiene I, Merlini G, Hazenberg BPC et al. 3 year follow-up results on a treatment of amyloid A (AA) amyloidosis: eficacy and safety of eprodisate, the first of new class of anti-amyloid compounds. Arthritis Rheum 54, (Supple):S538, 2006.

349. Kilinc M, Shinar Y, Tolun FI, Imrek SS, Livneh A. Molecular Diagnosis of familial Mediterranean fever in patients with familial Mediterranean fever in Kahramanmaras. Turk klinik Biyokimya Derg 4:121-125, 2006.

350. Kaplan B, Livneh A, Gallo G. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease. Br J Haematol. 136:723- 728, 2007

351. Mor A, Pillinger MH, Kishimoto M, Abeles AM, Livneh A. Familial Mediterranean fever. Successfully treated with etanercept. J Clin Rheumatol 13:38-40, 2007.

352. Livneh A. Amyloidosis of familial Mediterranean fever (FMF)-insights to FMF phenotype II. –Response to Ben Chetrit E. Harefuah 146: 243, 2007. 

353. Alaez C, Gazit E, Ibarrola B, Yaron M, Livneh A, Avishai O, Gorodezky C.  Distribution of HLA-B27 subtypes in ankylosing spondylitis in an Israeli population. Arch Med Res 38: 452-455. 2007

354. Tuglular S, Livneh A, Gorevic P,Gul A, Ozdogan H, Hawkins P, Dember L et al. Results of a sub-group analysis of a multi-center, randomized, placebo controlled trial for the treatment of amyloiod A (AA) amyloidosis-associated renal disease with eprodisate (NC-503) In patients with familial Mediterranean fever (FMF). WCN Post Congress Meeting, 2007.

355. Rabinovich E, Shinar Y, Leiba M, Ehrenfeld M, Langevitz P, Livneh A. Common FMF alleles may predispose to development of Behcet's disease with increased risk for venous thrombosis. Scand J Rheumatol 36:48-52, 2007.

356.Berkun Y, Padeh S, Reichman B, Zaks N, Rabinovich E, Lidar M, Shainberg B, Livneh A. A single testing of serum amyloid A levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever. ISR meeting . Book of Abstracts,  2007.

357.Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalçinkaya F, Ozen S, Majeed H, Ozdogan H, Kastner D, Booth D, Ben-Chetrit E, Pugnère D, Michelon C, Séguret F, Gershoni-Baruch R; International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean Fever. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum May; 56:1706-1712, 2007

358. Kaplan B, Shinar Y, Avisar C, Livneh A. Transthyretin amyloidosis in a patient of Iranian-Jewish extraction: a second Israeli-Jewish case. Clin Chem Lab Med  45:625-658,  2007.

359. Ben-Horin S, Bank I, Shinfeld A, Kachel E, Guetta V, Livneh A. Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis. Am J Cardiol  99: 1294-1297, 2007.

360. Dember LM, Hawkins PN, Hazenberg BP, Gorevic PD, Merlini G, Butrimiene I, Livneh A, Lesnyak O, Puéchal X, Lachmann HJ, Obici L, Balshaw R, Garceau D, Hauck W, Skinner M. Eprodisate for AA Amyloidosis Trial Group. Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med 356:2349-2360, 2007.

361. Shtrasburg S, Lidar M, Pras M, Pariente C, Gal R, Livneh A. Suppression of amyloidogenesis in a mouse model by corticosteroid intervention. Transl Res, 150: 66-72, 2007.

362. Hazenberg BP, Bijzet J, Limburg PC, Skinner M, Hawkins PN, Butrimiene I, Livneh A, Lesnyak O, Nasonov EL, Filipowicz-Sosnowska A, Gül A, Merlini G, Wiland P, Ozdogan H, Gorevic PD, Maïz HB, Benson MD, Direskeneli H, Kaarela K, Garceau D, Hauck W, Van Rijswijk MH. Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis. Amyloid. 14:133-140, 2007.

363. Wright DG, Kastner DL, Pollen GB & members of the systemic amyloidosis advisory group. Challenges and opportunities for systemic amyloidosis research. Summary of an advisory workshop sponsored by the NIH office of rare diseases, Bethesda, Maryland, June 20, 2006. Amyloid 14:103–112, 2007

364.Lesnyak O, Butrimiene I, Hazenberg BPC, Hawkins PN, Livneh A, Nasonov EL, Merlini G, Dember LM et al. Beneficial effect of eprodisate (NC-503) on the preservation of kidney function in AA amyloidosis patients: 3-year follow-up results. Ann Rheum Dis (Suppl II) 66:248, 2007.

365. Naimushin A, Livneh A. Black tongue. Harefuah 146:564-565, 572, 2007.

366. Lidar M, Livneh A. The diagnostic and therapeutic approach for familial Mediterranean fever: in the genetic era. Israeli J Med 6:20-25, 2007.

367.Tweezer-Zaks N, Zandman-Goddard G, Lidar M, Har-Zahav Y, Livneh A, Langevitz P. A long-term follow-up after cardiac transplantation in a lupus patient: case report and review of the literature. Ann N Y Acad Sci 1110:539-543, 2007.

368. Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 65:318-324, 2007.

369. Shinar Y, Kuchuk I, Menasherow S, Kolet M, Lidar M, Langevitz P, Livneh A. Unique spectrum of MEFV mutations in Iranian Jewish FMF patients--clinical and demographic significance. Rheumatology (Oxford) 46:1718-1722, 2007.

370. Tweezer-Zaks N, Doron-Libner A, Weiss P, Ben-Horin S, Barshack I, Lidar M, Livneh A. Familial Mediterranean fever and cryptogenic cirrhosis. Medicine (Baltimore). 86:355-362, 2007.

371. Berkun Y, Padeh S, Reichman B, Zaks N, Rabinovich E, Lidar M, Shainberg B, Livneh A. A single testing of serum amyloid A levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever. Semin Arthritis Rheum. 37:182-188, 2007.

372. Rabinovitch E, Harats D, Yaron P, Luvish T, Lidar M, Kedem R, Shaish A, Ben-Dov I, Livneh A. Familial Mediterranean fever gene and protection against asthma. Ann Allergy Asthma Immunol. 99: 517-521, 2007.

373. Kaplan B, Livneh A, Gallo G. Charge differences of deposits in AL and NALCDD. Skinner M, Berk JL, Connors LH, Seldin DC Eds XIth International Symposium on Amyloidosis, CRC Press, London. 13-15, 2008.

374. Lidar M, Hazenberg B.P, Bijzet J, Hauck W, Garceau D, Kedem R, Livneh A. Lack of correlation between amyloid A protein levels and clinical parameters in aspirated fat tissue of familial Mediterranean fever patients with secondary amyloidosis. Skinner M, Berk JL, Connors LH, Seldin DC Eds XIth International Symposium on Amyloidosis, CRC Press, London. 75-77, 2008.

375. Shtrasburg S, Lidar M, Pras M, Gal R, Livneh A. The effect of a variety of anti-Inflammatory drugs on murine amyloidogenesis. Skinner M, Berk JL, Connors LH, Seldin DC Eds XIth International Symposium on Amyloidosis, CRC Press, London. 93-95, 2008.

376. Shinar Y, Kaplan B, Avisar C, Livneh A.  A transthyretin mutation (V32A) in an Israeli patient with amyloidotic neuropathy localizes to a 3D mutation hotspot.  Skinner M, Berk JL, Connors LH, Seldin DC Eds XIth International Symposium on Amyloidosis, CRC Press, London. 193-195, 2008.

377. Kukuy OL, Kopolovic J, Blau A, Ben-David A, Lotan D, Shaked M, Shinar Y, Dinour D, Langevitz P, Livneh A. Mutations in the familial Mediterranean fever gene of patients with IgA nephropathy and other forms of glomerulonephritis. Clin Genet. 73:146-151, 2008.

378. Kaplan B, Ramirez-Alvarado M, Dispenzieri A, Zeldenrust SR, Leung N, Livneh A, Gallo G. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties. Clin Chem Lab Med 46:335-341, 2008.

379. Naimushin A, Livneh A. Aspirin and endoscopy. Harefuah 147:89-90, 2008.

380. Naimushin A, Livneh A. Neurogenic pulmonary edema. Harefuah 147:169-90, 2008.

381. Livneh A. Skills and practice in colchicne treatment of FMF. Invited lecture at The Fifth International Congress on Familial Mediterranean Fever and Systemic Autoinflammatory Diseases. Apr. 2008.

382. Shinar Y, Kosach Y, Lidar M, Livneh A, Godard G, Langevitz P. Can mutations in the FMF gene protect or alleviate systemic lupus erythematosus burden. Clin Exp Rheumatol 26:209, 2008.

383. Shinar Y, Feld O, Berkun Y, Navalenia I, Avisar C, Menasherow S, Padeh S, Livneh A, Rare MEFV exon 10 mutations in Israel. Clin Exp Rheumatol 26:199, 2008

384. Shinar Y, Golberg M, Navalenia I, Livneh A. Longevity and MEFV mutations: a study in mutation carriers. Clin Exp Rheumatol 26:199, 2008

385. Marek D, Berkun Y, Padeh S, Abu A, Resnik Wolf H, Pras M, Livneh A, Pras E. Is E 148Q a benign polymorphism or a disease causing mutation. Clin Exp Rheumatol 26:198, 2008.

386. Lidar M, Sharon M, Zaks N, Livneh A, Apter S. CT findings in familial Mediterranean fever patients during attacks and attack-free periods. Clin Exp Rheumatol 26:195, 2008.

387. Feld O, Shinar Y, Livneh A, Lidar M. MEFV mutation carriage in Israeli Jewish subjects subjects from ethnicities with low risk for familial Mediterranean fever. Clin Exp Rheumatol 26:195, 2008.

388. Lidar M, Kedem R, Langevitz P, Livneh A. Familial Mediterranean fever in Ashkenazi Jews: The mild end of the clinical spectrum. Clin Exp Rheumatol 26:195, 2008.

389. Kricheli T, Lidar M, Feld O, Langevitz P, Livneh A. Prolonged remission in familial Mediterranean fever. Clin Exp Rheumatol 26:195, 2008.

390. Shtrasburg S, Epstein Y, Pras M, Livneh A, Lidar M. Ambient temperature and amyloidogenesis in mice. Clin Exp Rheumatol 26:183, 2008.

391. Shtrasburg S, Livneh A, Pras M, Gal R, Lidar M. Attempts at suppression of amyloidogenesis in a mouse model by a variety of non-steroidal and other anti- inflammatory agents. Clin Exp Rheumatol 26:183, 2008.

392. Shtrasburg S, Lidar M, Pras M, Gal R, Livneh A. Tissue specific rate and amount of amyloid deposition in induced and natural amyloidosis. Clin Exp Rheumatol 26:183, 2008.

393. Pras E, Marek D, Padeh S, Abu A, Resnik Wolf H, Livneh A, Pras M, Berkun Y. Clinical disease among FMF heterozygotes. Clin Exp Rheumatol 26:177, 2008.

394. La Regina M, Livneh A, Manna R, Ozdogan H. Trends in colchicines treatment in familial Mediterranean fever (FMF). Clin Exp Rheumatol 26:177, 2008.

395. Lidar M, Livneh A. MEFV mutations and palindromic rheumatism: comment on the article by Canete et al. Arthritis Rheum 58:1885, 2008.

396. Tweezer-Zaks N, Rabinovich E, Lidar M, Livneh A. Interferon α as a treatment modality for colchicines-resistant familial Mediterranean fever. J Rheumatol 35:1362-5, 2008.

397. Lidar M, Zandman-Goddard G, Shinar Y, Zaks N, Livneh A, Langevitz P. Systemic lupus erythematosus and familial Mediterranean fever: A possible negative association between the two disease entities: report of four cases and review of the literature. Lupus. 17:663-9, 2008.

398. Golan S, Livneh A. ECG changes during ischemic brain infarct. Harefuah 147:568-9, 2008.

399. Lidar M, Livneh A. The utility of genetic testing in the diagnosis of familial Mediterranean fever. Neth J Med 66:261, 2008.

400. Lidar M, Doron A, Kedem R, Yosepovich A, Langevitz P, Livneh A. Appendectomy in familial Mediterranean fever: clinical, genetic and pathological findings. Clin Exp Rheumatol, 26:568-573, 2008.

401.Shtrasburg S, Livneh A, Pras M, Gal R, Lidar M. Therapeutic options for mouse amyloidogenesis; from NSAID to cyclophosphamide. Arthritis Rheum, 58(Suppl):S477,2008.

402.Lidar M, Kedem R, Berkun Y, Langevitz P, Livneh A. Characterization of familial Mediterranean fever in Ashkenazi Jews. Arthritis Rheum, 58(Suppl):S478,2008.

403. Kaplan B, Ramirez-Alvarado M, Sikkink L, Golderman S, Dispenzieri A, Livneh A, Gallo G. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease. Br J Haematol. 144:705-15, 2009.

404. Marek D, Berkun Y, Padeh S, Abul A, Resnik Wolf H, Pras M, Livnej A, Pras E. Clinical disease among FMF heterozygotes. ISR meeting . Book of Abstracts, 27, 2009.

405. Berkun Y, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, Padeh S. Familial Mediterranean fever in the first two years of life: a unique phenotype of a disease in evolution. ISR meeting . Book of Abstracts, 28, 2009.  

406. Feld O, Livneh A, Shinar Y, Berkun Y, Lidar M. MEFV mutation carriage in Israeli Jewish individuals from ethnicities with low risk for familial Mediterranean fever. J Hum Genet. 54:369-71, 2009

407. Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, Pras M, Pras E. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum. 60:1862-6. 2009.

408. Bezalel Y, Gershoni-Baruch R, Dagan E, Lidar M, Livneh A. The 3435T polymorphism in the ABCB1 gene and colchicine unresponsiveness in familial Mediterranean fever. Clin Exp Rheumatol.;27(Suppl 53):S103-4,2009.

409. Lidar M, Kedem R, Berkun Y, Langevitz P, Livneh A. Familial Mediterranean fever in Ashkenazi Jews: the mild end of the clinical spectrum. J Rheumatol. 37:422-5,2010.

410. Naimushin A, Livneh A. Atrial fibrillation in hospitalized patients: Retrospective analysis. The 10th international Dead Sea Symposium on Cardiac arrhythmias and Device Therapy. Book of Abstracts, 156, 2010. 

411. Naimushin A, Livneh A. Amonia as a cause for hepatic encephalopathy. Harefuah 149:113-4, 2010.

412. Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, Berkun Y. Familial Mediterranean fever in children presenting with attacks of fever alone. J Rheumatol. 37:865-9, 2010.

413. Danilesko I, Kivity S, Boris G, Kukuy O, Rachamimov R, Livneh A. SAA levels in Kidney transplanted FMF-amyloidosis patients. First national conference on FMF autoinflammatory diseases and amyloidosis. Book of Abstracts, 2, 2010.

414. Eshed I, Kushnir T, Livneh A, Langevitz P, Konen E, Lidar M. Insights into the pathogenesis of exertional leg pain in FMF. First national conference on FMF autoinflammatory diseases and amyloidosis. Book of Abstracts, 7, 2010.

415. Berkun Y, Levy R, Hurwitz A, Meir-Harel M, Lidar M, Livneh A, Padeh S. The familial Mediterranean fever gene (MEFV) as a modifier of PFAPA syndrome. First national conference on FMF autoinflammatory diseases and amyloidosis. Book of Abstracts, 8, 2010.

416. Ovadia A, Livneh A, Feld O, Be'eri A, Kukuy L, Rubinstein M, Ben-Zvi I, Bentenkur A, Or J, Navalania I, Nachum O, Barda-Saad M, Shinar Y. T cells subsets in autoinflammation. A study in FMF patients. First national conference on FMF autoinflammatory diseases and amyloidosis. Book of Abstracts, 11, 2010.

417.Naimushin A, Livneh A. The effect of the E148Q mutation on the secondary structure of pyrin. First  national conference on FMF autoinflammatory diseases and amyloidosis. Book of Abstracts, 12, 2010.

418. Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, Berkun Y. Familial Mediterranean fever in the first 2 years of life: A unique phenotype of disease in evolution. First national conference on FMF autoinflammatory diseases and amyloidosis. Book of Abstracts, 13, 2010.

419. Yahalom G, Kivity S, Lidar M, Livneh A. Coexistence of multiple sclerosis and familial Mediterranean fever. First  national conference on FMF autoinflammatory diseases and amyloidosis. Book of Abstracts, 15, 2010.

420. Marek D, Berkun Y, Padeh S, Abu A, Resnik Wolf H, Pras M, Livneh A, Pras E. Clinical disease among FMF heterozygotes. First national conference on FMF autoinflammatory diseases and amyloidosis. Book of Abstracts, 16, 2010.

421. Nussinovitch U  Nussinovitch N, Lidar M, Nussinovitch M, Volovitz B, Livneh A. Heart rate variability in uncomplicated FMF and in amyloidosis. First national conference on FMF autoinflammatory diseases and amyloidosis. Book of Abstracts, 17, 2010.

422. Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U. Heart rate variability in familial Mediterranean fever. Rheumatol Int 31:39-43, 2011

423. Fattal I, Shental N, Mevorach D, Anaya JM, Livneh A, Langevitz P, Zandman-Goddard G, Pauzner R, Lerner M, Blank M, Hincapie ME, Gafter U, Naparstek Y, Shoenfeld Y, Domany E, Cohen IR. An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology 130: 337-43, 2010

424.  Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, Berkun Y. Familial Mediterranean fever in the first two years of life: a unique phenotype of disease in evolution. J Pediatr 156:985-9, 2010.

425.  Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U. QT dispersion in uncomplicated familial Mediterranean fever. Clin Rheumatol 29: 1353-6.

426. Exertional leg pain as a manifestation of occult spondyloarthropathy in FMF patients: results of an MRI evaluation. ISR meeting . Book of Abstracts, 2010

427. Nussinovitch N, Livneh A, Katz K, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U. P wave dispersion in familial Mediterranean fever. Rheumatol Int 31:1591-4, 2011.

428.  Marek-Yagel D, Berkun Y, Padeh S, Lidar M, Shinar Y, Bar-Joseph I, Reznik-Wolf  H, Langevitz P, Livneh A, Pras E. Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever. Arthritis Care Res (Hoboken) 62:1294-8, 2010.

429. Berkun Y, Levy R, Hurwitz A, Meir-Harel M, Lidar M, Livneh A, Padeh S. The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome. Semin Arthritis Rheum 40:467-72, 2011

430.  Ben-Zvi I, Naimushin A, Livneh A. Aortic atheroma and splenic emboli. Harefuah. 149:279-82,

431. Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 7:105-12, 2011

432.  Yahalom G, Kivity S, Lidar M, Vaknin-Dembinsky A, Karussis D, Flechter S, Ben-Chetrit E, Livneh A. Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts. Eur J Neurol 18:1146-50, 2011

433.   Kaplan B, Livneh A, Sela BA. Immunoglobulin free light chain dimers in human diseases. ScientificWorldJournal 11:726-35, 2011

434.  Naimushin A, Eliasaf S, Livneh A. Clostridium difficile-associated diarrhea: causes and relationship to reactive arthritis. Harefuah 150:64-6, 201113:

435.    Nussinovitch U, Livneh A, Nussinovitch M, Volovitz B, Ben-Zvi I, Lidar M, Nussinovitch N. P-wave dispersion in systemic AA amyloidosis of familial Mediterranean fever. Clin Rheumatol 30: 1295- 8, 2011

436.    Nussinovitch U, Livneh A, Kaminer K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch N. Normal autonomic nervous system responses in uncomplicated familial Mediterranean fever: a comparative case-control study. Clin Rheumatol 30:1347-51, 2011

437.    Livneh A. Familial Mediterranean fever: a continuously challenging disease. Isr Med Assoc J 13:197-8, 2011

438.     Naimushin A, Lidar M, Ben Zvi I, Livneh A. The structural effect of the E148Q MEFV mutation on the pyrin protein: a study using a quantum chemistry model. Isr Med Assoc J 13:199-201, 2011

439.    Kivity S, Danilesko I, Ben-Zvi I, Gilburd B, Kukuy OL, Rahamimov R, Livneh A. Serum amyloid A levels in kidney-transplanted patients with familial Mediterranean fever-amyloidosis. Isr Med Assoc J 13:202-5, 2011.

440.    Livneh A. Practice and vision--current trends and perspectives in diagnosis of amyloidosis. Amyloid 18 Suppl 1:198-9, 2011. Erratum in: Amyloid 18 Suppl 1:199, 2011

441. Achiron A, Langevitz P, Livneh A. Takayasu's arteritis: new diagnostic tools and treatment. Harefuah  

 149:798-802, 2010.

442.    Ben-Zvi I, Brandt B, Berkun Y, Lidar M, Livneh A. The relative contribution of environmental and genetic factors to phenotypic variation in familial Mediterranean fever (FMF). Gene 491:260-3, 2012

443.     Nussinovitch U, Volovitz B, Nussinovitch M, Lidar M, Feld O, Nussinovitch N, Livneh A. Abnormal heart rate variability in AA amyloidosis of familial Mediterranean fever. Amyloid 18:206-10, 2011

444. Kukuy OL, Ben Zvi I, Ben David A, Kopolovic J, Volkov A, Shinar Y, Dinour D, Livneh A. Renal biopsy in familial Mediterranean fever with proteinuria – is it justified? ISR meeting . Book of Abstracts:21, 2012

445.  Lidar N, Yonath H, Shecter N, Sikron F, Sadezki S, Langevitz P, Livneh A, Pras E. Incomplete response to colchicines in M694V homozygous FMF patients. ISR meeting . Book of Abstracts:22, 2012

446.  Feld O, Yahalom G, Livneh A. Neurologic and other systemic manifestations in FMF: Published and own experience. Best Pract Res Clin Rheumatol. 26:119-33, 2012

447. Ben-Zvi I, Livneh A. The Israeli Annual FMF, Amyloidosis and Other autoinflammatory diseases meeting (July 2011): a bridge spanning these entities. Isr Med Assoc J 14:219-20, 2012

448. Nussinovitch U, Ben-Zvi I, Livneh A. QT variability in amyloidosis of familial Mediterranean fever. Isr Med Assoc J 14:225-8, 2012

449. Ben-Zvi I, Danilesko I, Yahalom G, Kukuy O, Rahamimov R, Livneh A, Kivity S. Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever. Isr Med Assoc J 14:221-4, 2012

450. Nussinovitch U, Kaminer K, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch N, Livneh A. QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients. Clin Rheumatol 31:795-9, 2012.

451. Shinar Y, Rubinstein M, Ben-Chetrit E, Berkun Y, Ben-Zvi I, Lidar M, Lowenthal R, Livneh A. HLA typing in amyloidosis of FMF. XIII international symposium on amyloidosis. Book of abstracts, 190, 2012.

452. Kaplan B, Ziv T, Livneh A. A simple amyloid typing procedure based on proteomic approach. XIII international symposium on amyloidosis. Book of abstracts, 136, 2012.

453. Kukuy OL, Ben-Zvi I, Ben-David A, Kopolovic J, Volkov A, Shinar Y, Dinour D, Livneh A. Renal biopsy in FMF with proteinuria – Is it justified. XIII international symposium on amyloidosis. Book of abstracts, 161, 2012.

454. Ben-Zvi I, Kivity S, Danilesko I, Yahalom G, Kukuy OL, Rahamimov R, Livneh A. Lessons from FMF-amyloidosis kidney transplanted patients. XIII international symposium on amyloidosis. Book of abstracts, 154, 2012.

455. Livneh A. Diagnosis. Severity scoring system for paediatric FMF. Nat Rev Rheumatol 8:309-10, 2012

456. Ben-Zvi I, Krichely-Vachdi T, Feld O, Lidar M, Kivity S, Livneh A. Prolonged disease free interval in FMF: a distinct subset with a unique clinical demographic and molecular characteristics. Annal Rheum Dis;71 (Suppl3):287, 2012.

457. Nussinovitch U, Nussinovitch N, Nussinovitch M, Volovitz B, Feld O, Ben-Zvi I, Livneh A. QT dispersion in amyloidosis due to familial Mediterranean fever. Rheumatol Int 32:1945-8, 2012

458. Nussinovitch U, Livneh A, Volovitz B, Nussinovitch M, Ben-Zvi I, Lidar M, Nussinovitch N. Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF). Clin Rheumatol 31:1093-6,  2012

459. Shinar Y, Kosach E, Langevitz P, Zandman-Goddard G, Pauzner R, Rabinovich E, Livneh A, Lidar M. FMF gene (MEFV) mutations as a modifier of SLE. 8th International congress on autoimmunity. Book of Abstracts, 2012.

460. Pras E, Lidar M, Yonath H, Shecter N, Sikron F, Sadezki S, Langevitz P, Livneh A. Incomplete response to colchicines in M694V homozygote FMF patients. 8th International congress on autoimmunity. Book of Abstracts, 2012.

461. Shinar Y, Kosach E, Langevitz P, Zandman-Goddard G, Pauzner R, Rabinovich E, Livneh A, Lidar M. Familial Mediterranean FeVer gene (MEFV) mutations as a modifier of systemic lupus erythematosus. Lupus 21:993-8, 2012

462. Berkun Y, Karban A, Padeh S, Pras E, Shinar Y, Lidar M, Livneh A, Bujanover Y. NOD2/CARD15 

gene mutations in patients with familial Mediterranean fever. Semin Arthritis Rheum 42:84-8, 2012

463. Camus D, Shinar Y, Aamar S, Langevitz P, Ben-Zvi I, Livneh A, Lidar M.'Silent' carriage of two   

   familial Mediterranean fever gene mutations in large families with only a single identified patient. 

   Clin Genet 82:288-91, 2012

464. Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I, Costa JM, De Leener A, Gattorno M, Kania U, Kone-Paut I, Lezer S, Livneh A, Moix I, Nishikomori R, Ozen S, Phylactou L, Risom L, Rowczenio D, Sarkisian T, van Gijn ME, Witsch-Baumgartner M, Morris M, Hoffman HM, Touitou I; European Molecular Genetics Quality Network. Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 71:1599-605, 2012

465. Shtrasburg S, Pras M, Rabinovich E, Gal R, Livneh A, Lidar M. Attempts at suppression of amyloidogenesis in a mouse model by a variety of anti-inflammatory agents. Autoimmun Rev 12:18-21, 2012

466. Lidar M, Yonath H, Shechter N, Sikron F, Sadetzki S, Langevitz P, Livneh A, Pras E. Incomplete response to colchicine in M694V homozygote FMF patients. Autoimmun Rev 12:72-6. 2012.

467. Eshed I, Kushnir T, Livneh A, Langevitz P, Ben-Zvi I, Konen E, Lidar M. Exertional leg pain as a manifestation of occult spondyloarthropathy in familial Mediterranean fever: an MRI evaluation. Scand J Rheumatol 41:482-6, 2012

468. Leibou L, Frand J, Sadeh M, Lossos A, Kremer E, Livneh A, Yarnitsky D, Herman O, Dabby R. Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy. Isr Med Assoc J 14:662-5, 2012

469. Berkun Y, Wason S, Brik R, Butbul Y, Ben-Chetrit E, Hashkes PJ, Livneh A, Ozen S, Ozdogan H, Faulkner R, Davis MW. Pharmacokinetics of colchicine in pediatric and adult patients with familial Mediterranean fever. Int J Immunopathol Pharmacol 25:1121-30, 2012

470. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI; PLIFY-EXT Investigators. Apixaban for extended treatment of venous thromboembolism. N Engl J Med 368:699-708, 2013

471. Kaplan B, Golderman S, Yahalom G, Yeskaraev R, Ziv T, Aizenbud BM, Sela BA, Livneh A. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis. J Immunol Methods 390 (1-2): 74-80, 2013.

472. Kushnir T, Eshed I, Heled Y, Livneh A, Langevitz P, Ben Zvi I, Konen E, Lidar M. Exertional muscle pain in familial Mediterranean fever patients evaluated by MRI and 31P magnetic resonance spectroscopy. Clin Radiol 68:371-5, 2013

473. Twig G, Livneh A, Vivante A, Afek A, Shamiss A, Derazne E, Tzur D, Ben-Zvi I, Tirosh A, Barchana M, Shohat T, Golan E, Amital H. Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents. ISR meeting . Book of Abstracts 17, 2013

474. Ben-Zvi I, Herskovizh C, Kassel Y, Livneh A. Characterization of mutation negative FMF. ISR meeting . Book of Abstracts 16, 2013

475.    Lidar M, Doron A, Barzilai A, Feld O, Zaks N, Livneh A, Langevitz P. Erysipelas-like erythema as the presenting feature of familial Mediterranean fever. J Eur Acad Dermatol Venereol. 27:912-5, 2013.

476. Lidar M, Shinar Y, Goldberg M, Ben-Zvi I, Langevitz P, Livneh A. E148Q MEFV mutation carriage and longevity in individuals of Ashkenazi origin. Immunol Res. 56:371-5, 2013.

477. Shinar Y, Breuer G, Hashkes P. CAPS diagnosis and treatment in an Israeli family Ped Rheumatol. 11 (Suppl 1): A40, 2013.

478. Demirkaya E, Acikel C, Gul A, Gattorno M, Ben-Chetrit E, Ozdogan AH, Hashkes P, Polat A, Karadag O, Livneh A, Ozen S. Developing a new severity score for FMF Ped Rheumatol. 11 (Suppl 1): A81, 2013.

479. Rosman Y, Eshed I, Livneh A, Lidar M. Exertional leg pain and spondyloarthropathy in FMF. Ped Rheumatol. 11 (Suppl 1): A64, 2013.

480. Eviatar T, Zaks N, Kukuy OL, Livneh A, Lidar M. The effect of pregnancy on disease course in FMF Ped Rheumatol. 11 (Suppl 1): A63, 2013.

481. Shinar Y, Berkun Y, Livneh A, Padeh S. Genetic analysis practice prior to FMF diagnosis. Ped Rheumatol. 11 (Suppl 1): A41, 2013.

482. Feld O, Ben Zvi I, Kukuy OL, Livneh A. Long-term IV colchicine in oral colchicine failure. Ped Rheumatol. 11 (Suppl 1): A39, 2013.

483. Brenner R, Kivity S, Shinar Y, Liphshitz I, Ben-Shetrit E, Livneh A, Ben Zvi I. Cancer in FMF: a population based study in Israel. Ped Rheumatol. 11 (Suppl 1): A38, 2013.

484. Epstein A, Ben-Zvi I, Shinar Y, Lidar M, Ben-Horin S, Livneh A. Co-Occurance of Crohn's and FMF. Ped Rheumatol. 11 (Suppl 1): A37, 2013.

485. Ben Zvi I, Herskovizh C, Kassel Y, Livneh A. Characterization of genetic-negative FMF. Ped Rheumatol. 11 (Suppl 1): A36, 2013.

486. Ben-Zvi I, Kukuy OL, Lidar M, Feld O, Perski O, Kivity S, Langevitz P, Pistrom B, Livneh A. Anakinra for colchicine resistant FMF. Ped Rheumatol. 11 (Suppl 1): A35, 2013.

487. Kukuy OL, Livneh A, Ben-David A, Kopolovic J, Volkov A, Shinar Y, Holtzman E, Dinour D, Ben Zvi I. Proteinuria in FMF – prediction of nephropathy type. Ped Rheumatol. 11 (Suppl 1):A34, 2013.

488. Grabowitz L, Kukuy OL, Lidar M, Ben Zvi I, Feld O, Kesel Y, Livneh A. Microscopic hematuria in FMF. Ped Rheumatol. 11 (Suppl 1): A33, 2013.

489. Nussinovitch U, Livneh A. Normal HRV in colchicine-resistant FMF. Ped Rheumatol. 11 (Suppl 1): A31, 2013.

490. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 369:799-808, 2013

491. Brenner R, Kivity S, Shinar Y, Liphshitz I, Ben-Shetrit E, Livneh A. Cancer in FMF: a population based study in Israel. Third Israeli conference on FMF, reactive amyloidosis and other autoinflammatory diseases. Book of abstracts 10, 2013.

492. Ben-Zvi I, Kukuy OL, Lidar M, Feld O, Perski O, Kivity S, Langevitz P, Pistrom B, Livneh A. Anakinra for colchicine resistant FMF. Third Israeli conference on FMF, reactive amyloidosis and other autoinflammatory diseases. Book of abstracts 7, 2013.

493. Twig G, Livneh A, Vivante A, Ben-Zvi I, Tirosh A, Afek A, Shamiss A, Derazne E, Tzur D, Ben-Ami Shore D, Leiba A, Meydan C, Amital H. The natural progression of cardiovascular risk factors among young men with familial Mediterranean fever. Third Israeli conference on FMF, reactive amyloidosis and other autoinflammatory diseases. Book of abstracts 14, 2013.

494. Epstein A, Ben-Zvi I, Shinar Y, Ben-Horin S, Cohen R, Livneh A. IL-23 –R mutation may underlie increased susceptibility to develop Crohn's disease in FMF. Third Israeli conference on FMF, reactive amyloidosis and other autoinflammatory diseases. Book of abstracts 18, 2013.

495. Shinar Y, Berkun Y, Livneh A, Padeh S. The impact of genetic analysis on familial Mediterranean fever diagnosis. Third Israeli conference on FMF, reactive amyloidosis and other autoinflammatory diseases. Book of abstracts 14, 2013.

496. La Regina M, Ben-Chetrit E, Gasparyan AY, Livneh A, Ozdogan H, Manna R. Current trends in colchicine treatment in familial Mediterranean fever. Clin Exp Rheumatol. 2013;31 (3 Suppl 77):41-6.

497. Kukuy O, Livneh A, Ben-David A, Kopolovic J, Volkov A, Shinar Y, Holtzman E, Dinour D, Ben-Zvi I. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients. J Rheumatol. 40:2083-7, 2013.

498. Giat E, Ben Zvi I, Livneh A. Familial amyloid neuropathy caused by transthyretin fibril deposition (ATTR). Medicine (Israel) 36-40, 2013.

499. Hentgen V, Grateau G, Kone-Paut I, Livneh A, Padeh S, Rozenbaum M, Amselem S, Gershoni-Baruch R, Touitou I, Ben-Chetrit E. Evidence-based recommendations for the practical management of Familial Mediterranean Fever. Semin Arthritis Rheum. 43:387-91, 2013

500. Fattal I, Shental N, Molad Y, Gabrielli A, Pokroy-Shapira E, Oren S, Livneh A, Langevitz P, Pauzner R, Sarig O, Gafter U, Domany E, Cohen IR. Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA. Immunology.141:276-85, 2014.

501. Ben-Zvi I, Krichely-Vachdi T, Feld O, Lidar M, Kivity S, Livneh A. Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study. Orphanet J Rare Dis. 9:9:3, 2014.

502. Nussinovitch N, Kivity S, Ben-Zvi I, Livneh A. Normal P Wave Dispersion in Colchicine-Resistant FMF Patients. .J Cardiol Therapeu 2:45-48, 2014

503. Twig G, Livneh A, Vivante A, Afek A, Shamiss A, Derazne E, Tzur D, Ben-Zvi I, Tirosh A, Barchana M, Shohat T, Golan E, Amital H. Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents. Ann Rheum Dis.73:704-9, 2014.

504. Asman A, Chouraqui P, Marcu-Malina V, Matetzky S, Segev A, Fefer P, Agranat O, Koltakov A, Hod H, Livneh A, Bank I. Acute coronary syndromes are associated with a reduction of VLA-1+ peripheral blood T cells and their enrichment in coronary artery plaque aspirates. Immunobiology 219: 302-7, 2014.

505. Kaplan B, Golderman S, Aizenbud BM, Esev K, Leiba M, Ben-Zvi I, Livneh A. Immunoglobulin free light chain monomer-dimer patterns in the diagnosis of AL amyloidosis. The XIVth International Symposium on Amyloidosis, Indianapolis, Indiana, United States 27 April, 2014.

506. Ozen S, Kuemmerle-Deschner J, Cantarini L, Cimaz R, Quartier P, Gul A, Kone-Paut I, Spalding S, Zeft A, Simon A, Hashkes P, Ventgen V, Kallinich T, Savic S, Foeldvari I, Frenkel J, Machein U, Livneh A, Lachmann HJ. Patient Journey and treatment route to use first biologic in rare autoinflammatory diseases: An international retrospective chart review. Oral presentation in EULAR Annual European Congress of Rheumatology, Paris 11 June 2014.

507. Twig G, Livneh A, Vivante A, Afek A, Derazne E, Leiba A, Ben-Ami Shor D, Meydan C, Ben-Zvi I, Tzur D, Furer A, Imazio M, Adler Y, Amital H. Cardiovascular and metabolic risk factors in inherited autoinflammation. EULAR Annual European Congress of Rheumatology, Paris 11 June 2014.

508. Kaplan B, Golderman S, Aizenbud BM, Esev K, Kukuy O, Leiba M, Ben-Zvi I, Livneh A. Immunoglobulin free light chain monomer-dimer patterns in the diagnosis of AL amyloidosis. In Beckerma BK, Liepnieks JJ, Benson MD Eds. Proceedings: The XIVth International Symposium on Amyloidosis, Indianapolis, Indiana, USA 260-2, 2014.

509. Fattal I, Rimer J, Shental N, Molad Y, Gabrielli A, Livneh A, Sarig O, Goldberg I, Gafter U, Domany E, Cohen IR. Pemphigus vulgaris is characterized by low IgG reactivities to specific self-antigens along with high IgG reactivity to desmoglein 3. Immunology 143:374-80, 2014

510. Kaplan B, Golderman S, Aizenbud B, Esev K, Kukuy O, Leiba M, Livneh A, Ben-Zvi I. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study. Am J Hematol. 89:882-8, 2014.

511. Livneh A, Ben-Zvi I. Pearls from the Third Israeli Conference on FMF, other autoinflammatory disorders and AA amyloidosis. Isr Med Assoc J. 16:269-70, 2014.

512. Ben-Zvi I, Livneh A. Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial. Isr Med Assoc J. 16:271-3, 2014.

513. Twig G, Livneh A, Vivante A, Afek A, Derazne E, Leiba A, Shor DB, Meydan C, Ben-Zvi I, Tzur D, Furer A, Imazio M, Adler Y, Amital H. Cardiovascular and metabolic risk factors in inherited autoinflammation. J Clin Endocrinol Metab. 99:E2123-8, 2014.

514. Eshed I, Rosman Y, Livneh A, Kedem R, Langevitz P, Ben-Zvi I, Lidar M. Exertional leg pain in familial Mediterranean fever: a manifestation of an underlying enthesopathy and a marker of more severe disease. Arthritis Rheumatol. 66:3221-6. 2014.

515. Ben-Zvi I, Lidar M, Giat E, Kukuy L, Zafrir Y, Grossman C, Rosman Y, Livneh A. Clinical picture in Adulthood and unusual and peculiar clinical features of FMF. In: Gattorno M Ed. Familial Mediterranean fever. Springer Switzerland. Chapter 4:47- 80, 2015.

516. Demirkaya E, Livneh A. Evaluation of the current disease scoring systems in familial Mediterranean fever. . In: Gattorno M Ed. Familial Mediterranean fever. Springer Switzerland. Chapter 7:107- 118, 2015.

517. Ben-Zvi I, Herskovizh C, Kukuy O, Kassel Y, Grossman C, Livneh A. Familial Mediterranean fever without MEFV mutations: a case-control study. Orphanet J Rare Dis. 10:34, 2015

518. Nussinovich N, Esev K, Lidar M, Nussinovitch U, Livneh A. Normal heart rate variability in colchicine-resistant FMF patients. Isr Med Assoc J.17:306-9. 2015.

519. Shinar Y, Tohami T, Livneh A, Schiby G, Hirshberg A, Nagar M, Goldstein I, Cohen R, Kukuy O, Shubman O, Sharabi Y, Gonzalez-Roca E, Arostegui JI, Rechavi G, Amariglio N, Salomon O. Acquired familial Mediterranean fever associated with a somatic MEFV mutation in a patient with JAK2 associated post-polycythemia myelofibrosis. Orphanet J Rare Dis. 10:86, 2015.

520. Fattal I, Shental N, Ben-Dor S, Molad Y, Gabrielli A, Pokroy-Shapira E, Oren S, Livneh A, Langevitz P, Zandman-Goddard G, Sarig O, Margalit R, Gafter U, Domany E, Cohen IR. Guanine polynucleotides are self-antigens for human natural autoantibodies and are significantly reduced in the human genome. Immunology. 146:401-10. 2015

521. Ben-David H, Hornung V, Ebert T, Livneh A, Ben-Zvi I. Toll like receptor 2 is overexpressed in FMF patients during attacks and inhibited by colchicine treatment. Pediatr Rheumatol 13(Suppl 1):P74, 2015.

522. Lidar M, Livneh A, Ben-Zvi I, Cohen R, Berkun Y, Hashkes P, Peleg H, Kessel A, Almog R, Kali L, Slobodin G, Rozenbaum M, Shinar Y. The clinical phenotype of Israeli patients with Q703K mutation in the NLRP3 gene Pediatr Rheumatol. 13(Suppl 1):P42, 2015.

523. Roitman AJ, Zvi I, Kukuy O, Livneh A. Factors affecting cardiovascular morbidity in young FMF patients. A comparative analysis in colchicine treated FMF patients with and without cardiovascular disease. Pediatr Rheumatol. 13(Suppl 1):O47, 2015.

524. Ben-Zvi I, Shinar Y, Cohen R, Grossman C, Kukuy O, Livneh A. Genetic analysis of MEFV mutation negative familial Mediterranean fever for non-MEFV mutations is rarely effective. Pediatr Rheumatol. 13(Suppl 1):P26, 2015.

525. Shinar Y, Hashkes PJ, Cohen R, Kessel A, Tirosh I, Padeh S, Arostegui J, Livneh A. Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency. Pediatr Rheumatol. 13(Suppl 1):P48, 2015.

526. Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Perski O, Bornstein G, Grossman C, Lidar M, Livneh A Anakinra (kineret) for colchicine resistant familial Mediterranean fever (CRFMF) – A randomized, double blind, placebo-controlled study Oral presentation in 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases. Dresden, Germany, 2015.

527. Shinar Y, Giat E, Cohen R, Livneh A. Assessment of the pathogenicity of the p.K695R and p.A744S Mediterranean fever gene variants Pediatr Rheumatol. 13(Suppl 1):P122, 2015.

528. Dechtman ID, Ben-Zvi I, Yael S, Cohen R, Nachum E, Lipey A, Sternik L, Kachel E, Kassif Y, Shinfeld A, Spigelstein D, Lavee J, Raanani E, Livneh .A. MEFV mutation carriage as possible predisposition factor for the development of Post Pericardiotomy Syndrome (PPS). Pediatr Rheumatol. 13(Suppl 1):P76, 2015.

529. Ben-Zvi I, Kassel Y, Kukuy O, Herskovizh C, Grossman C, Livneh .A. Featuring the phenotype of the FMF prototype. Pediatr Rheumatol. 13(Suppl 1):P78, 2015.

530. Pras E, Dahan S, Epstein A, Ben-Zvi I, Marek-Yagel D, Shinar Y, Lidar M, Livneh A. Over representation of the A allele in the IL23R rs1004819 polymorphism in M694V homozygote non-responsive FMF patients. Pediatr Rheumatol. 13(Suppl 1):P87, 2015.

531. Kukuy O, Leiba A, Mendel L, Benor A, Giat E, Perski O, Feld O, Kessel Y, Ben Zvi I, Lidar M, Livneh A. Arterial stiffness as a model to dissect chronic inflammation in FMF. Pediatr Rheumatol. 13(Suppl 1):P93, 2015.

532. Livneh A. Chronic inflammation in FMF. Oral presentation in 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases. Dresden, Germany, 2015

533. Rottenstreich A, Machol K, Eisenstein EM, Padeh S, Klar A, Livneh A, Berkun Y. Behçet's disease and cerebral sinus vein thrombosis in children: a case study and review of the literature. Clin Exp Rheumatol. 33 (6 Suppl 94):S163-8, 2015.

534. Shouval R, Livneh A, Ben-Zvi I. Interleukin 1 inhibitors--a new horizon in the treatment of familial Mediterranean fever. Harefuah.154:716-9, 2015

535. Ben-Zvi I, Goldenberg I, Matetzky S, Grossman C, Elis A, Gavrielov-Yusim N, Livneh A. The impact of inflammatory rheumatic diseases on the presentation, severity, and outcome of acute coronary syndrome. Clin Rheumatol. 35:233-7, 2016.

536. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, Ozdogan H, Abu I, Gattorno M, Hawkins PN, Yuce S, Kallinich T, Bilginer Y, Kastner D, Carmona L. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 75:644-51, 2016.

537. Demirkaya E, Acikel C, Hashkes P, Gattorno M, Gul A, Ozdogan H, Turker T, Karadag O, Livneh A, Ben-Chetrit E, Ozen S; FMF Arthritis Vasculitis and Orphan disease Research in pediatric rheumatology (FAVOR). Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF). Ann Rheum Dis. 75:1051-6, 2016.

538. Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Perski O, Bornstein G, Grossman C, Lidar M, Livneh A Anakinra for colchicine resistant FMF – A randomized, double blind, placebo-controlled trial . Annual meeting of the Israeli Society of Rheumatology. Book of Abstracts 23, 2016.

539. Ben-David H, Hornung V, Ebert T, Livneh A, Lidar M, Ebert TS, Persky O, Feld O, Grossman H, Bornstein G, Ben-Zvi I. Toll-like receptor 2 is overexpressed in familial Mediterranean fever  patients and is inhibited by treatment with colchicine. Annual meeting of the Israeli Society of Rheumatology. Book of Abstracts 36, 2016.

540. Haj Yahia S, Ben Zvi I, Livneh A. Colchicine intoxication in FMF patients using clarithromycin for treatment of Helicobacter Pylori. Annual meeting of the Israeli Society of Rheumatology. Book of Abstracts 34, 2016.

541. Lidar M, Shinar Y, Livneh A, Ben-Zvi I, Cohen R, Berkun Y, Hashkes P, Peleg H, Kessel A, Almog R, Kali L, Slobodin G, Rozenbaum M, Goldzweig O, Bratz Y, Pras E. The prevalence of the NLRP3 – Q703K allele among Israelis suspected of harboring an autoinflammatory disease. Annual meeting of the Israeli Society of Rheumatology. Book of Abstracts 35, 2016.

542. Ozen S, Kuemmerle-Deschner JB, Cimaz R, Livneh A, Quartier P, Kone-Paut I, Zeft A, Spalding S, Gul A, Hentgen V, Savic S, Foeldvari I, Frenkel J, Cantarini L, Patel D, Weiss J, Marinsek N, Degun R, Lomax KG, Lachmann HJ. International retrospective chart review of treatment patterns in severe FMF, TRAPS and MKD/HIDS. Arthritis Care Res (Hoboken). Accepted. 2016.

543. Shinar Y, Cohen R, Marcu-Malina V, Goldstein I, Menza-Vilaro A, Menza-Vilaro A, Gonzalez-Roca E, Arostegui J. I, Livneh A, Oron-Karni V. Crohn‘s disease associated with a higher rate of mevalonate kinase somatic mosaicism in circulating monocytes. Eur J Hum Genet 24 (E-Supple 1):90, 2016.

544. Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Lecturer S, Perski O, Bornstein G, Grossman C, Harari G, Lidar M, Livneh A. Anakinra for colchicine resistant familial Mediterranean fever - A randomized, double blind, placebo-controlled trial. Arthritis Rheumatol. Accepted. 2016.